Wylie Vale - Publications

Affiliations: 
Salk Institute for Biological Studies, La Jolla, CA, United States 
Area:
Neuroendocrinology

375 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Dautzenberg FM, Grigoriadis DE, Hauger RL, Risbrough VB, Steckler T, Vale WW, Valentino RJ. Corticotropin-releasing factor receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f19/2019.4  0.575
2013 Flandreau EI, Bourke CH, Ressler KJ, Vale WW, Nemeroff CB, Owens MJ. Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala. Psychoneuroendocrinology. 38: 1349-61. PMID 23267723 DOI: 10.1016/J.Psyneuen.2012.11.020  0.796
2012 Neufeld-Cohen A, Kelly PA, Paul ED, Carter RN, Skinner E, Olverman HJ, Vaughan JM, Issler O, Kuperman Y, Lowry CA, Vale WW, Seckl JR, Chen A, Jamieson PM. Chronic activation of corticotropin-releasing factor type 2 receptors reveals a key role for 5-HT1A receptor responsiveness in mediating behavioral and serotonergic responses to stressful challenge. Biological Psychiatry. 72: 437-47. PMID 22704666 DOI: 10.1016/J.Biopsych.2012.05.005  0.485
2012 Wiater E, Vale W. Roles of activin family in pancreatic development and homeostasis. Molecular and Cellular Endocrinology. 359: 23-9. PMID 22406274 DOI: 10.1016/J.Mce.2012.02.015  0.73
2012 Bilezikjian LM, Justice NJ, Blackler AN, Wiater E, Vale WW. Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin. Molecular and Cellular Endocrinology. 359: 43-52. PMID 22330643 DOI: 10.1016/J.Mce.2012.01.025  0.733
2012 Spike BT, Kelber JA, Kalathur M, Booker E, Lipianskaya J, Klemke R, Vale W, Wahl G, Gray PC. Abstract 3493: Soluble ALK4 extracellular domain antagonizes the cancer/stem cell phenotype caused by Nodal and Cripto signaling in mammary epithelia Cancer Research. 72: 3493-3493. DOI: 10.1158/1538-7445.Am2012-3493  0.719
2011 Jamieson PM, Cleasby ME, Kuperman Y, Morton NM, Kelly PA, Brownstein DG, Mustard KJ, Vaughan JM, Carter RN, Hahn CN, Hardie DG, Seckl JR, Chen A, Vale WW. Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and hyperglycaemia on a high-fat diet. Diabetologia. 54: 2392-403. PMID 21667214 DOI: 10.1007/S00125-011-2205-6  0.445
2011 Fekete EM, Zhao Y, Szücs A, Sabino V, Cottone P, Rivier J, Vale WW, Koob GF, Zorrilla EP. Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress. British Journal of Pharmacology. 164: 1959-75. PMID 21627635 DOI: 10.1111/J.1476-5381.2011.01512.X  0.398
2011 Huising MO, Pilbrow AP, Matsumoto M, van der Meulen T, Park H, Vaughan JM, Lee S, Vale WW. Glucocorticoids differentially regulate the expression of CRFR1 and CRFR2α in MIN6 insulinoma cells and rodent islets. Endocrinology. 152: 138-50. PMID 21106875 DOI: 10.1210/en.2010-0791  0.467
2011 Kuperman Y, Issler O, Vaughan J, Bilezikjian L, Vale W, Chen A. Expression and regulation of corticotropin-releasing factor receptor type 2β in developing and mature mouse skeletal muscle. Molecular Endocrinology (Baltimore, Md.). 25: 157-69. PMID 21084379 DOI: 10.1210/Me.2010-0308  0.55
2010 Neufeld-Cohen A, Tsoory MM, Evans AK, Getselter D, Gil S, Lowry CA, Vale WW, Chen A. A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery. Proceedings of the National Academy of Sciences of the United States of America. 107: 19020-5. PMID 20937857 DOI: 10.1073/Pnas.1013761107  0.596
2010 Looyenga BD, Wiater E, Vale W, Hammer GD. Inhibin-A antagonizes TGFbeta2 signaling by down-regulating cell surface expression of the TGFbeta coreceptor betaglycan. Molecular Endocrinology (Baltimore, Md.). 24: 608-20. PMID 20160125 DOI: 10.1210/Me.2008-0374  0.739
2010 Huising MO, van der Meulen T, Vaughan JM, Matsumoto M, Donaldson CJ, Park H, Billestrup N, Vale WW. CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner. Proceedings of the National Academy of Sciences of the United States of America. 107: 912-7. PMID 20080775 DOI: 10.1073/pnas.0913610107  0.36
2010 Neufeld-Cohen A, Evans AK, Getselter D, Spyroglou A, Hill A, Gil S, Tsoory M, Beuschlein F, Lowry CA, Vale W, Chen A. Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits. Molecular Psychiatry. 15: 426-41, 339. PMID 19884890 DOI: 10.1038/Mp.2009.115  0.656
2010 Huang MM, Overstreet DH, Knapp DJ, Angel R, Wills TA, Navarro M, Rivier J, Vale W, Breese GR. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization. The Journal of Pharmacology and Experimental Therapeutics. 332: 298-307. PMID 19843974 DOI: 10.1124/Jpet.109.159186  0.326
2010 Neufeld-Cohen A, Evans AK, Getselter D, Spyroglou A, Hill A, Gil S, Tsoory M, Beuschlein F, Lowry CA, Vale W, Chen A. Urocortin-1 and-2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits Molecular Psychiatry. 15: 442. DOI: 10.1038/mp.2009.135  0.572
2009 Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, Singru PS, Nilsson KP, Simon R, Schubert D, Eisenberg D, Rivier J, Sawchenko P, Vale W, Riek R. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science (New York, N.Y.). 325: 328-32. PMID 19541956 DOI: 10.1126/Science.1173155  0.304
2009 Kelber JA, Panopoulos AD, Shani G, Booker EC, Belmonte JC, Vale WW, Gray PC. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways. Oncogene. 28: 2324-36. PMID 19421146 DOI: 10.1038/Onc.2009.97  0.564
2009 Wiater E, Lewis KA, Donaldson C, Vaughan J, Bilezikjian L, Vale W. Endogenous betaglycan is essential for high-potency inhibin antagonism in gonadotropes. Molecular Endocrinology (Baltimore, Md.). 23: 1033-42. PMID 19372236 DOI: 10.1210/Me.2009-0021  0.762
2009 Sztainberg Y, Kuperman Y, Issler O, Gil S, Vaughan J, Rivier J, Vale W, Chen A. A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 2186-96. PMID 19246489 DOI: 10.1096/Fj.08-128066  0.55
2009 Ciarmela P, Wiater E, Smith SM, Vale W. Presence, actions, and regulation of myostatin in rat uterus and myometrial cells. Endocrinology. 150: 906-14. PMID 18845635 DOI: 10.1210/En.2008-0880  0.752
2008 Justice NJ, Yuan ZF, Sawchenko PE, Vale W. Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system. The Journal of Comparative Neurology. 511: 479-96. PMID 18853426 DOI: 10.1002/Cne.21848  0.381
2008 Hao Z, Huang Y, Cleman J, Jovin IS, Vale WW, Bale TL, Giordano FJ. Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation. Proceedings of the National Academy of Sciences of the United States of America. 105: 3939-44. PMID 18308934 DOI: 10.1073/pnas.0712366105  0.489
2008 Ciarmela P, Wiater E, Vale W. Activin-A in myometrium: characterization of the actions on myometrial cells. Endocrinology. 149: 2506-16. PMID 18239071 DOI: 10.1210/En.2007-0692  0.738
2008 Kelber JA, Shani G, Booker EC, Vale WW, Gray PC. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal. The Journal of Biological Chemistry. 283: 4490-500. PMID 18089557 DOI: 10.1074/Jbc.M704960200  0.541
2008 Korupolu RV, Muenster U, Read JD, Vale W, Fischer WH. Activin A/bone morphogenetic protein (BMP) chimeras exhibit BMP-like activity and antagonize activin and myostatin. The Journal of Biological Chemistry. 283: 3782-90. PMID 18056265 DOI: 10.1074/jbc.M704530200  0.348
2008 Shani G, Fischer WH, Justice NJ, Kelber JA, Vale W, Gray PC. GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth. Molecular and Cellular Biology. 28: 666-77. PMID 17991893 DOI: 10.1128/Mcb.01716-07  0.577
2008 Gray PC, Shani G, Aung K, Kelber J, Vale W. Cripto binds transforming growth factor β (TGF-β) and inhibits TGF-β signaling (Molecular and Cellular Biology (2006) 26, 24, (9268-9278)) Molecular and Cellular Biology. 28: 7260. DOI: 10.1128/Mcb.01609-08  0.557
2008 Wiater E, Vale W. 4 Activins and Inhibins Cold Spring Harbor Monograph Archive. 50: 79-120. DOI: 10.1101/087969752.50.79  0.765
2007 Tabarin A, Diz-Chaves Y, Consoli D, Monsaingeon M, Bale TL, Culler MD, Datta R, Drago F, Vale WW, Koob GF, Zorrilla EP, Contarino A. Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysis. The European Journal of Neuroscience. 26: 2303-14. PMID 17953621 DOI: 10.1111/j.1460-9568.2007.05856.x  0.5
2007 Rissman RA, Lee KF, Vale W, Sawchenko PE. Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 6552-62. PMID 17567816 DOI: 10.1523/Jneurosci.5173-06.2007  0.308
2007 Rivier J, Gulyas J, Kunitake K, DiGruccio M, Cantle JP, Perrin MH, Donaldson C, Vaughan J, Million M, Gourcerol G, Adelson DW, Rivier C, Taché Y, Vale W. Stressin1-A, a potent corticotropin releasing factor receptor 1 (CRF1)-selective peptide agonist. Journal of Medicinal Chemistry. 50: 1668-74. PMID 17335188 DOI: 10.1021/jm0613875  0.576
2006 Chen A, Brar B, Choi CS, Rousso D, Vaughan J, Kuperman Y, Kim SN, Donaldson C, Smith SM, Jamieson P, Li C, Nagy TR, Shulman GI, Lee KF, Vale W. Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America. 103: 16580-5. PMID 17050686 DOI: 10.1073/Pnas.0607337103  0.505
2006 Gray PC, Shani G, Aung K, Kelber J, Vale W. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling. Molecular and Cellular Biology. 26: 9268-78. PMID 17030617 DOI: 10.1128/Mcb.01168-06  0.57
2006 Henry B, Vale W, Markou A. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9142-52. PMID 16957071 DOI: 10.1523/Jneurosci.1494-06.2006  0.688
2006 Chen A, Zorrilla E, Smith S, Rousso D, Levy C, Vaughan J, Donaldson C, Roberts A, Lee KF, Vale W. Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 5500-10. PMID 16707802 DOI: 10.1523/Jneurosci.3955-05.2006  0.558
2006 Wiater E, Harrison CA, Lewis KA, Gray PC, Vale WW. Identification of distinct inhibin and transforming growth factor beta-binding sites on betaglycan: functional separation of betaglycan co-receptor actions. The Journal of Biological Chemistry. 281: 17011-22. PMID 16621788 DOI: 10.1074/Jbc.M601459200  0.715
2006 Carlin KM, Vale WW, Bale TL. Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis. Proceedings of the National Academy of Sciences of the United States of America. 103: 3462-7. PMID 16492754 DOI: 10.1073/pnas.0511320103  0.524
2006 Smith SM, Vaughan JM, Donaldson CJ, Fernandez RE, Li C, Chen A, Vale WW. Cocaine- and amphetamine-regulated transcript is localized in pituitary lactotropes and is regulated during lactation. Endocrinology. 147: 1213-23. PMID 16339196 DOI: 10.1210/En.2005-1392  0.54
2005 Muenster U, Harrison CA, Donaldson C, Vale W, Fischer WH. An activin-A/C chimera exhibits activin and myostatin antagonistic properties. The Journal of Biological Chemistry. 280: 36626-32. PMID 16129674 DOI: 10.1074/jbc.M507236200  0.349
2005 Nemeroff CB, Vale WW. The neurobiology of depression: inroads to treatment and new drug discovery. The Journal of Clinical Psychiatry. 66: 5-13. PMID 16124836  0.341
2005 Chen AM, Perrin MH, Digruccio MR, Vaughan JM, Brar BK, Arias CM, Lewis KA, Rivier JE, Sawchenko PE, Vale WW. A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proceedings of the National Academy of Sciences of the United States of America. 102: 2620-5. PMID 15701705 DOI: 10.1073/Pnas.0409583102  0.511
2005 Chen A, Perrin M, Brar B, Li C, Jamieson P, Digruccio M, Lewis K, Vale W. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids. Molecular Endocrinology (Baltimore, Md.). 19: 441-58. PMID 15514029 DOI: 10.1210/Me.2004-0300  0.584
2004 Vale W, Wiater E, Gray P, Harrison C, Bilezikjian L, Choe S. Activins and inhibins and their signaling. Annals of the New York Academy of Sciences. 1038: 142-7. PMID 15838109 DOI: 10.1196/Annals.1315.023  0.743
2004 Harrison CA, Wiater E, Gray PC, Greenwald J, Choe S, Vale W. Modulation of activin and BMP signaling. Molecular and Cellular Endocrinology. 225: 19-24. PMID 15451563 DOI: 10.1016/J.Mce.2004.02.008  0.735
2004 Weisinger RS, Blair-West JR, Burns P, Denton DA, Purcell B, Vale W, Rivier J, Weisinger HS, May CN. Cardiovascular effects of long-term central and peripheral administration of urocortin, corticotropin-releasing factor, and adrenocorticotropin in sheep. Endocrinology. 145: 5598-604. PMID 15319360 DOI: 10.1210/en.2004-0432  0.354
2004 Greenwald J, Vega ME, Allendorph GP, Fischer WH, Vale W, Choe S. A flexible activin explains the membrane-dependent cooperative assembly of TGF-beta family receptors. Molecular Cell. 15: 485-9. PMID 15304227 DOI: 10.1016/J.Molcel.2004.07.011  0.307
2004 Smith SM, Vaughan JM, Donaldson CJ, Rivier J, Li C, Chen A, Vale WW. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism. Endocrinology. 145: 5202-9. PMID 15271883 DOI: 10.1210/En.2004-0708  0.567
2004 Risbrough VB, Hauger RL, Roberts AL, Vale WW, Geyer MA. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 6545-52. PMID 15269266 DOI: 10.1523/JNEUROSCI.5760-03.2004  0.575
2004 Harrison CA, Gray PC, Fischer WH, Donaldson C, Choe S, Vale W. An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors. The Journal of Biological Chemistry. 279: 28036-44. PMID 15123686 DOI: 10.1074/Jbc.M402782200  0.316
2004 Bale TL, Hoshijima M, Gu Y, Dalton N, Anderson KR, Lee KF, Rivier J, Chien KR, Vale WW, Peterson KL. The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. Proceedings of the National Academy of Sciences of the United States of America. 101: 3697-702. PMID 14990799 DOI: 10.1073/Pnas.0307324101  0.511
2004 Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annual Review of Pharmacology and Toxicology. 44: 525-57. PMID 14744257 DOI: 10.1146/annurev.pharmtox.44.101802.121410  0.53
2004 Chen A, Blount A, Vaughan J, Brar B, Vale W. Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids. Endocrinology. 145: 2445-57. PMID 14736736 DOI: 10.1210/En.2003-1570  0.523
2004 Brar BK, Chen A, Perrin MH, Vale W. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides. Endocrinology. 145: 1718-29. PMID 14670995 DOI: 10.1210/En.2003-1023  0.556
2004 Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjøs OD, Latchman DS, Lee KF, Vale W. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology. 145: 24-35; discussion 21. PMID 12970163 DOI: 10.1210/En.2003-0689  0.537
2003 Takabe K, Wang L, Leal AM, Macconell LA, Wiater E, Tomiya T, Ohno A, Verma IM, Vale W. Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats. Hepatology (Baltimore, Md.). 38: 1107-15. PMID 14578849 DOI: 10.1053/Jhep.2003.50483  0.726
2003 Luckey A, Wang L, Jamieson PM, Basa NR, Million M, Czimmer J, Vale W, Taché Y. Corticotropin-releasing factor receptor 1-deficient mice do not develop postoperative gastric ileus. Gastroenterology. 125: 654-9. PMID 12949710 DOI: 10.1016/S0016-5085(03)01069-2  0.312
2003 Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Baban K, Affolter M, Vale WW, Izpisua Belmonte JC, Choe S. Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membered cystine knot protein. The Journal of Bone and Joint Surgery. American Volume. 85: 52-8. PMID 12925610 DOI: 10.2106/00004623-200300003-00010  0.72
2003 Bale TL, Vale WW. Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 5295-301. PMID 12832554  0.499
2003 Li C, Chen P, Vaughan J, Blount A, Chen A, Jamieson PM, Rivier J, Smith MS, Vale W. Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. Endocrinology. 144: 3216-24. PMID 12810578 DOI: 10.1210/En.2002-0087  0.571
2003 Chen A, Vaughan J, Vale WW. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways. Molecular Endocrinology (Baltimore, Md.). 17: 1622-39. PMID 12764078 DOI: 10.1210/Me.2003-0054  0.502
2003 Bale TL, Anderson KR, Roberts AJ, Lee KF, Nagy TR, Vale WW. Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold. Endocrinology. 144: 2580-7. PMID 12746321 DOI: 10.1210/En.2002-0091  0.517
2003 Adams BA, Tello JA, Erchegyi J, Warby C, Hong DJ, Akinsanya KO, Mackie GO, Vale W, Rivier JE, Sherwood NM. Six novel gonadotropin-releasing hormones are encoded as triplets on each of two genes in the protochordate, Ciona intestinalis. Endocrinology. 144: 1907-19. PMID 12697698 DOI: 10.1210/En.2002-0216  0.353
2003 Gray PC, Harrison CA, Vale W. Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proceedings of the National Academy of Sciences of the United States of America. 100: 5193-8. PMID 12682303 DOI: 10.1073/pnas.0531290100  0.325
2003 Greenwald J, Groppe J, Gray P, Wiater E, Kwiatkowski W, Vale W, Choe S. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Molecular Cell. 11: 605-17. PMID 12667445 DOI: 10.1016/S1097-2765(03)00094-7  0.73
2003 Harrison CA, Gray PC, Koerber SC, Fischer W, Vale W. Identification of a functional binding site for activin on the type I receptor ALK4. The Journal of Biological Chemistry. 278: 21129-35. PMID 12665502 DOI: 10.1074/jbc.M302015200  0.318
2003 Bale TL, Giordano FJ, Vale WW. A new role for corticotropin-releasing factor receptor-2: suppression of vascularization. Trends in Cardiovascular Medicine. 13: 68-71. PMID 12586442 DOI: 10.1016/S1050-1738(02)00214-1  0.538
2003 Wiater E, Vale W. Inhibin is an antagonist of bone morphogenetic protein signaling. The Journal of Biological Chemistry. 278: 7934-41. PMID 12493742 DOI: 10.1074/Jbc.M209710200  0.748
2002 Bale TL, Lee KF, Vale WW. The role of corticotropin-releasing factor receptors in stress and anxiety. Integrative and Comparative Biology. 42: 552-5. PMID 21708750 DOI: 10.1093/Icb/42.3.552  0.541
2002 Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Izpisua Belmonte JC, Choe S. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature. 420: 636-42. PMID 12478285 DOI: 10.1038/Nature01245  0.715
2002 Vetter DE, Li C, Zhao L, Contarino A, Liberman MC, Smith GW, Marchuk Y, Koob GF, Heinemann SF, Vale W, Lee KF. Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nature Genetics. 31: 363-9. PMID 12091910 DOI: 10.1038/Ng914  0.309
2002 Valdez GR, Inoue K, Koob GF, Rivier J, Vale W, Zorrilla EP. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Research. 943: 142-50. PMID 12088848 DOI: 10.1016/S0006-8993(02)02707-5  0.32
2002 Bale TL, Giordano FJ, Hickey RP, Huang Y, Nath AK, Peterson KL, Vale WW, Lee KF. Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proceedings of the National Academy of Sciences of the United States of America. 99: 7734-9. PMID 12032352 DOI: 10.1073/Pnas.102187099  0.526
2002 Liu X, Nagarajan RP, Vale W, Chen Y. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor. Febs Letters. 519: 93-8. PMID 12023024 DOI: 10.1016/S0014-5793(02)02718-7  0.332
2002 Martínez V, Wang L, Rivier JE, Vale W, Taché Y. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. The Journal of Pharmacology and Experimental Therapeutics. 301: 611-7. PMID 11961064 DOI: 10.1124/jpet.301.2.611  0.335
2002 Gray PC, Bilezikjian LM, Vale W. Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan. Molecular and Cellular Endocrinology. 188: 254-60. PMID 11911962 DOI: 10.1016/S0303-7207(02)00037-0  0.332
2002 Leal AM, Takabe K, Wang L, Donaldson CJ, MacConell LA, Bilezikjian LM, Verma IM, Vale W. Effect of adenovirus-mediated overexpression of follistatin and extracellular domain of activin receptor type II on gonadotropin secretion in vitro and in vivo. Endocrinology. 143: 964-9. PMID 11861519 DOI: 10.1210/Endo.143.3.8667  0.419
2002 Bale TL, Picetti R, Contarino A, Koob GF, Vale WW, Lee KF. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 193-9. PMID 11756502  0.515
2002 Bale TL, Picetti R, Contarino A, Koob GF, Vale WW, Lee K. Mice Deficient for Both Corticotropin-Releasing Factor Receptor 1 (CRFR1) and CRFR2 Have an Impaired Stress Response and Display Sexually Dichotomous Anxiety-Like Behavior The Journal of Neuroscience. 22: 193-199. DOI: 10.1523/Jneurosci.22-01-00193.2002  0.515
2001 Lee S, Smith GW, Vale W, Lee KF, Rivier C. Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression. Alcoholism, Clinical and Experimental Research. 25: 427-33. PMID 11290855 DOI: 10.1111/J.1530-0277.2001.Tb02231.X  0.531
2000 Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. The Journal of Comparative Neurology. 428: 191-212. PMID 11064361 DOI: 10.1002/1096-9861(20001211)428:2<191::Aid-Cne1>3.0.Co;2-U  0.333
2000 Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature. 404: 411-4. PMID 10746731 DOI: 10.1038/35006129  0.751
2000 Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nature Genetics. 24: 410-4. PMID 10742108 DOI: 10.1038/74263  0.58
2000 Spina MG, Basso AM, Zorrilla EP, Heyser CJ, Rivier J, Vale W, Merlo-Pich E, Koob GF. Behavioral effects of central administration of the novel CRF antagonist astressin in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 230-9. PMID 10693150 DOI: 10.1016/S0893-133X(99)00108-6  0.383
2000 Gray PC, Greenwald J, Blount AL, Kunitake KS, Donaldson CJ, Choe S, Vale W. Identification of a binding site on the type II activin receptor for activin and inhibin. The Journal of Biological Chemistry. 275: 3206-12. PMID 10652306 DOI: 10.1074/Jbc.275.5.3206  0.32
1999 Contarino A, Dellu F, Koob GF, Smith GW, Lee KF, Vale W, Gold LH. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1. Brain Research. 835: 1-9. PMID 10448190 DOI: 10.1016/S0006-8993(98)01158-5  0.31
1999 Rivier JE, Kirby DA, Lahrichi SL, Corrigan A, Vale WW, Rivier CL. Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat. Journal of Medicinal Chemistry. 42: 3175-82. PMID 10447963 DOI: 10.1021/jm9902133  0.504
1999 Basso AM, Spina M, Rivier J, Vale W, Koob GF. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology. 145: 21-30. PMID 10445369 DOI: 10.1007/s002130051028  0.324
1999 Cervini L, Theobald P, Corrigan A, Craig AG, Rivier C, Vale W, Rivier J. Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutions. Journal of Medicinal Chemistry. 42: 761-8. PMID 10052982 DOI: 10.1021/jm980607e  0.46
1999 Turnbull AV, Smith GW, Lee S, Vale WW, Lee KF, Rivier C. CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation. Endocrinology. 140: 1013-7. PMID 9927337 DOI: 10.1210/endo.140.2.6675  0.474
1999 Turnbull AV, Vaughan J, Rivier JE, Vale WW, Rivier C. Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat. Endocrinology. 140: 71-8. PMID 9886809 DOI: 10.1210/endo.140.1.6419  0.547
1998 Lovejoy DA, Hewett-Emmett D, Porter CA, Cepoi D, Sheffield A, Vale WW, Tashian RE. Evolutionarily conserved, "acatalytic" carbonic anhydrase-related protein XI contains a sequence motif present in the neuropeptide sauvagine: the human CA-RP XI gene (CA11) is embedded between the secretor gene cluster and the DBP gene at 19q13.3. Genomics. 54: 484-93. PMID 9878252 DOI: 10.1006/Geno.1998.5585  0.547
1998 Greenwald J, Le V, Corrigan A, Fischer W, Komives E, Vale W, Choe S. Characterization of the extracellular ligand-binding domain of the type II activin receptor. Biochemistry. 37: 16711-8. PMID 9843440 DOI: 10.1021/Bi981939O  0.35
1998 Rivier J, Gulyas J, Corrigan A, Martinez V, Craig AG, Taché Y, Vale W, Rivier C. Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat. Journal of Medicinal Chemistry. 41: 5012-9. PMID 9836619 DOI: 10.1021/jm980426c  0.54
1998 Koerber SC, Gulyas J, Lahrichi SL, Corrigan A, Craig AG, Rivier C, Vale W, Rivier J. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges. Journal of Medicinal Chemistry. 41: 5002-11. PMID 9836618 DOI: 10.1021/jm980350k  0.452
1998 Lovejoy DA, Aubry JM, Turnbull A, Sutton S, Potter E, Yehling J, Rivier C, Vale WW. Ectopic expression of the CRF-binding protein: minor impact on HPA axis regulation but induction of sexually dimorphic weight gain. Journal of Neuroendocrinology. 10: 483-91. PMID 9700675 DOI: 10.1046/j.1365-2826.1998.00206.x  0.689
1998 Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee KF. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 20: 1093-102. PMID 9655498 DOI: 10.1016/S0896-6273(00)80491-2  0.383
1998 Rivier J, Lahrichi SL, Gulyas J, Erchegyi J, Koerber SC, Craig AG, Corrigan A, Rivier C, Vale W. Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges. Journal of Medicinal Chemistry. 41: 2614-20. PMID 9651165 DOI: 10.1021/jm980164e  0.477
1998 Bilezikjian LM, Turnbull AV, Corrigan AZ, Blount AL, Rivier CL, Vale WW. Interleukin-1beta regulates pituitary follistatin and inhibin/activin betaB mRNA levels and attenuates FSH secretion in response to activin-A. Endocrinology. 139: 3361-4. PMID 9645713 DOI: 10.1210/endo.139.7.6190  0.474
1997 Chen Y, Bhushan A, Vale W. Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase. Proceedings of the National Academy of Sciences of the United States of America. 94: 12938-43. PMID 9371779 DOI: 10.1073/Pnas.94.24.12938  0.314
1997 Miranda A, Lahrichi SL, Gulyas J, Koerber SC, Craig AG, Corrigan A, Rivier C, Vale W, Rivier J. Constrained corticotropin-releasing factor antagonists with i-(i + 3) Glu-Lys bridges. Journal of Medicinal Chemistry. 40: 3651-8. PMID 9357532 DOI: 10.1021/jm970311t  0.584
1997 Aubry JM, Turnbull AV, Pozzoli G, Rivier C, Vale W. Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary. Endocrinology. 138: 1621-6. PMID 9075723 DOI: 10.1210/endo.138.4.5050  0.558
1997 Maecker H, Desai A, Dash R, Rivier J, Vale W, Sapolsky R. Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure. Brain Research. 744: 166-70. PMID 9030428 DOI: 10.1016/S0006-8993(96)01207-3  0.531
1996 Rivier J, Jiang GC, Lahrichi SL, Porter J, Koerber SC, Rizo J, Corrigan A, Gierasch L, Hagler A, Vale W, Rivier C. Dose relationship between GnRH antagonists and pituitary suppression. Human Reproduction (Oxford, England). 11: 133-47. PMID 9147108 DOI: 10.1093/Humrep/11.Suppl_3.133  0.564
1996 Heinrichs SC, Stenzel-Poore MP, Gold LH, Battenberg E, Bloom FE, Koob GF, Vale WW, Pich EM. Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor. Neuroscience. 74: 303-11. PMID 8865183 DOI: 10.1016/0306-4522(96)00140-6  0.56
1996 Turnbull AV, Vale W, Rivier C. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. European Journal of Pharmacology. 303: 213-6. PMID 8813571 DOI: 10.1016/0014-2999(96)00141-0  0.587
1996 Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale W, Koob GF. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science (New York, N.Y.). 273: 1561-4. PMID 8703220 DOI: 10.1126/science.273.5281.1561  0.382
1995 Rivier JE, Jiang G, Porter J, Hoeger CA, Craig AG, Corrigan A, Vale W, Rivier CL. Gonadotropin-releasing hormone antagonists: novel members of the azaline B family. Journal of Medicinal Chemistry. 38: 2649-62. PMID 7629804 DOI: 10.1021/Jm00014A017  0.567
1995 Tsuchida K, Vaughan JM, Wiater E, Gaddy-Kurten D, Vale WW. Inactivation of activin-dependent transcription by kinase-deficient activin receptors. Endocrinology. 136: 5493-503. PMID 7588300 DOI: 10.1210/Endo.136.12.7588300  0.721
1995 Gulyas J, Rivier C, Perrin M, Koerber SC, Sutton S, Corrigan A, Lahrichi SL, Craig AG, Vale W, Rivier J. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proceedings of the National Academy of Sciences of the United States of America. 92: 10575-9. PMID 7479843 DOI: 10.1073/pnas.92.23.10575  0.56
1994 Miranda A, Koerber SC, Gulyas J, Lahrichi SL, Craig AG, Corrigan A, Hagler A, Rivier C, Vale W, Rivier J. Conformationally restricted competitive antagonists of human/rat corticotropin-releasing factor. Journal of Medicinal Chemistry. 37: 1450-9. PMID 8182703  0.499
1994 Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 2579-84. PMID 8182429 DOI: 10.1523/Jneurosci.14-05-02579.1994  0.615
1994 Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale W. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proceedings of the National Academy of Sciences of the United States of America. 91: 8777-81. PMID 8090722 DOI: 10.1073/Pnas.91.19.8777  0.376
1994 Parkes D, Kasckow J, Vale W. Carbon monoxide modulates secretion of corticotropin-releasing factor from rat hypothalamic cell cultures. Brain Research. 646: 315-8. PMID 8069681 DOI: 10.1016/0006-8993(94)90097-3  0.401
1994 Kasckow JW, Parkes DG, Owens MJ, Stipetic MD, Han JH, Nemeroff CB, Vale WW. The BE (2)-M17 neuroblastoma cell line synthesizes and secretes corticotropin-releasing factor. Brain Research. 654: 159-62. PMID 7982090 DOI: 10.1016/0006-8993(94)91583-0  0.586
1993 Pich EM, Koob GF, Heilig M, Menzaghi F, Vale W, Weiss F. Corticotropin-releasing factor release from the mediobasal hypothalamus of the rat as measured by microdialysis. Neuroscience. 55: 695-707. PMID 8413932 DOI: 10.1016/0306-4522(93)90435-I  0.371
1993 Hernandez JF, Kornreich W, Rivier C, Miranda A, Yamamoto G, Andrews J, Taché Y, Vale W, Rivier J. Synthesis and relative potencies of new constrained CRF antagonists. Journal of Medicinal Chemistry. 36: 2860-7. PMID 8411001 DOI: 10.1021/Jm00072A004  0.497
1993 Rivier J, Rivier C, Galyean R, Miranda A, Miller C, Craig AG, Yamamoto G, Brown M, Vale W. Single point D-substituted corticotropin-releasing factor analogues: effects on potency and physicochemical characteristics. Journal of Medicinal Chemistry. 36: 2851-9. PMID 8411000  0.496
1993 Stenzel-Poore M, Vale WW, Rivier C. Relationship between antigen-induced immune stimulation and activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology. 132: 1313-8. PMID 8382598 DOI: 10.1210/endo.132.3.8382598  0.674
1993 Parkes D, Rivest S, Lee S, Rivier C, Vale W. Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamus. Molecular Endocrinology (Baltimore, Md.). 7: 1357-67. PMID 8264665 DOI: 10.1210/mend.7.10.8264665  0.547
1992 Knollema S, Brown ER, Vale W, Sawchenko PE. Novel hypothalamic and preoptic sites of prepro-melanin-concentrating hormone messenger ribonucleic Acid and Peptide expression in lactating rats. Journal of Neuroendocrinology. 4: 709-17. PMID 21554658 DOI: 10.1111/j.1365-2826.1992.tb00222.x  0.343
1992 Press M, Caprio S, Tamborlane WV, Bhushan R, Thorner M, Vale W, Rivier J, Sherwin RS. Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes. 41: 17-21. PMID 1727733 DOI: 10.2337/Diab.41.1.17  0.312
1992 Risold PY, Fellmann D, Rivier J, Vale W, Bugnon C. Immunoreactivities for antisera to three putative neuropeptides of the rat melanin-concentrating hormone precursor are coexpressed in neurons of the rat lateral dorsal hypothalamus. Neuroscience Letters. 136: 145-9. PMID 1641182 DOI: 10.1016/0304-3940(92)90035-6  0.34
1992 Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology. 130: 3378-86. PMID 1597149 DOI: 10.1210/Endo.130.6.1597149  0.645
1992 Petraglia F, Woodruff TK, Botticelli G, Botticelli A, Genazzani AR, Mayo KE, Vale W. Gonadotropin-releasing hormone, inbibin, and activin in human placenta: Evidence for a common cellular localization Journal of Clinical Endocrinology and Metabolism. 74: 1184-1188. PMID 1569165 DOI: 10.1210/Jcem.74.5.1569165  0.363
1992 Bittencourt JC, Presse F, Arias C, Peto C, Vaughan J, Nahon JL, Vale W, Sawchenko PE. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. The Journal of Comparative Neurology. 319: 218-45. PMID 1522246 DOI: 10.1002/Cne.903190204  0.347
1992 Imaki T, Vale W, Sawchenko PE. Regulation of corticotropin-releasing factor mRNA in neuroendocrine and autonomic neurons by osmotic stimulation and volume loading. Neuroendocrinology. 56: 633-40. PMID 1488095 DOI: 10.1159/000126286  0.356
1992 Vaughan JM, Rivier J, Spiess J, Peng C, Chang JP, Peter RE, Vale W. Isolation and characterization of hypothalamic growth-hormone releasing factor from common carp, Cyprinus carpio. Neuroendocrinology. 56: 539-49. PMID 1475012 DOI: 10.1159/000126272  0.633
1992 Stenzel-Poore MP, Heldwein KA, Stenzel P, Lee S, Vale WW. Characterization of the genomic corticotropin-releasing factor (CRF) gene from Xenopus laevis: two members of the CRF family exist in amphibians. Molecular Endocrinology (Baltimore, Md.). 6: 1716-24. PMID 1448118 DOI: 10.1210/mend.6.10.1448118  0.618
1992 Rivier C, Rivest S, Vale W. Alcohol-induced inhibition of LH secretion in intact and gonadectomized male and female rats: possible mechanisms. Alcoholism, Clinical and Experimental Research. 16: 935-41. PMID 1443432 DOI: 10.1111/j.1530-0277.1992.tb01896.x  0.546
1992 Parkes D, Vale W. Secretion of melanin-concentrating hormone and neuropeptide-EI from cultured rat hypothalamic cells. Endocrinology. 131: 1826-31. PMID 1327720 DOI: 10.1210/endo.131.4.1327720  0.379
1992 Jezová D, Bartanusz V, Westergren I, Johansson BB, Rivier J, Vale W, Rivier C. Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier. Endocrinology. 130: 1024-9. PMID 1310274 DOI: 10.1210/endo.130.2.1310274  0.575
1992 Swerdloff RS, Tom LkS, Salameh W, Steiner B, Peterson M, Rivier J, Vale W, Bhasin S. Male contraception: Achievement of reversible azoospermia by combined gonadotropin releasing hormone antagonist and testosterone enanthate Contraception. 46: 193-195. DOI: 10.1016/0010-7824(92)90039-V  0.344
1992 Rivier J, Theobald P, Hoeger C, Craig A, Perrin M, Porter J, Corrigan A, Koerber S, Hagler A, Vale W, Rivier C. GnRH antagonists: A synopsis Contraception. 46: 109-112. DOI: 10.1016/0010-7824(92)90014-K  0.565
1991 Nahon JL, Presset F, Schoepfer R, Vale W. Identification of a Single Melanin-Concentrating Hormone Messenger Ribonucleic Acid in Coho Salmon: Structural Relatedness with 7SL Ribonucleic Acid. Journal of Neuroendocrinology. 3: 173-83. PMID 19215519 DOI: 10.1111/j.1365-2826.1991.tb00260.x  0.344
1991 Imaki T, Nahan JL, Rivier C, Sawchenko PE, Vale W. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 585-99. PMID 2002354 DOI: 10.1523/Jneurosci.11-03-00585.1991  0.535
1991 Rivier C, Vale W. Effect of recombinant activin-A on gonadotropin secretion in the female rat. Endocrinology. 129: 2463-5. PMID 1935780 DOI: 10.1210/endo-129-5-2463  0.575
1991 Brown MR, Vaughan J, Jimenez LL, Vale W, Baird A. Transforming growth factor-beta: role in mediating serum-induced endothelin production by vascular endothelial cells. Endocrinology. 129: 2355-60. PMID 1935770 DOI: 10.1210/Endo-129-5-2355  0.442
1991 Rivier C, Vale W. Effect of recombinant inhibin on follicle-stimulating hormone secretion by the female rat: interaction with a gonadotropin-releasing hormone antagonist and estrogen. Endocrinology. 129: 2160-5. PMID 1915096 DOI: 10.1210/endo-129-4-2160  0.584
1991 Rivier C, Corrigan A, Vale W. Effect of recombinant human inhibin on gonadotropin secretion by the male rat. Endocrinology. 129: 2155-9. PMID 1915095 DOI: 10.1210/endo-129-4-2155  0.576
1991 Carroll RS, Corrigan AZ, Vale W, Chin WW. Activin stabilizes follicle-stimulating hormone-beta messenger ribonucleic acid levels. Endocrinology. 129: 1721-1726. PMID 1915062 DOI: 10.1210/Endo-129-4-1721  0.335
1991 Rivier C, Schwall R, Mason A, Burton L, Vale W. Effect of recombinant inhibin on gonadotropin secretion during proestrus and estrus in the rat. Endocrinology. 128: 2223-8. PMID 1902163 DOI: 10.1210/endo-128-5-2223  0.572
1991 Feng YJ, Shalts E, Xia LN, Rivier J, Rivier C, Vale W, Ferin M. An inhibitory effects of interleukin-1a on basal gonadotropin release in the ovariectomized rhesus monkey: reversal by a corticotropin-releasing factor antagonist. Endocrinology. 128: 2077-82. PMID 1900786 DOI: 10.1210/endo-128-4-2077  0.5
1991 Corrigan AZ, Bilezikjian LM, Carroll RS, Bald LN, Schmelzer CH, Fendly BM, Mason AJ, Chin WW, Schwall RH, Vale W. Evidence for an autocrine role of activin B within rat anterior pituitary cultures. Endocrinology. 128: 1682-4. PMID 1900235 DOI: 10.1210/Endo-128-3-1682  0.347
1991 Rivier C, Schwall R, Mason A, Burton L, Vaughan J, Vale W. Effect of recombinant inhibin on luteinizing hormone and follicle-stimulating hormone secretion in the rat. Endocrinology. 128: 1548-54. PMID 1900232 DOI: 10.1210/endo-128-3-1548  0.585
1991 Plotsky PM, Kjaer A, Sutton SW, Sawchenko PE, Vale W. Central activin administration modulates corticotropin-releasing hormone and adrenocorticotropin secretion. Endocrinology. 128: 2520-5. PMID 1850353 DOI: 10.1210/Endo-128-5-2520  0.394
1991 Gonzalez-Manchon C, Bilezikjian LM, Corrigan AZ, Mellon PL, Vale W. Activin-A modulates gonadotropin-releasing hormone secretion from a gonadotropin-releasing hormone-secreting neuronal cell line Neuroendocrinology. 54: 373-377. PMID 1758579 DOI: 10.1159/000125916  0.383
1991 Theobald P, Porter J, Rivier C, Corrigan A, Hook W, Siraganian R, Perrin M, Vale W, Rivier J. Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N omega-cyanoguanidino moieties. Journal of Medicinal Chemistry. 34: 2395-402. PMID 1714956 DOI: 10.1021/Jm00112A013  0.577
1991 Imaki J, Imaki T, Vale W, Sawchenko PE. Distribution of corticotropin-releasing factor mRNA and immunoreactivity in the central auditory system of the rat. Brain Research. 547: 28-36. PMID 1713530 DOI: 10.1016/0006-8993(91)90571-C  0.32
1991 Horn F, Bilezikjian LM, Perrin MH, Bosma MM, Windle JJ, Huber KS, Blount AL, Hille B, Vale W, Mellon PL. Intracellular responses to gonadotropin-releasing hormone in a clonal cell line of the gonadotrope lineage. Molecular Endocrinology (Baltimore, Md.). 5: 347-55. PMID 1653891 DOI: 10.1210/mend-5-3-347  0.381
1991 Rivier C, Vale W. Stimulatory effect of interleukin-1 on adrenocorticotropin secretion in the rat: is it modulated by prostaglandins? Endocrinology. 129: 384-8. PMID 1647302 DOI: 10.1210/endo-129-1-384  0.555
1990 Lee S, Imaki T, Vale W, Rivier C. Effect of prenatal exposure to ethanol on the activity of the hypothalamic-pituitary-adrenal axis of the offspring: Importance of the time of exposure to ethanol and possible modulating mechanisms. Molecular and Cellular Neurosciences. 1: 168-77. PMID 19912768 DOI: 10.1016/1044-7431(90)90022-V  0.564
1990 McMaster D, Itoh H, Maccannell KL, Rivier J, Rivier C, Vale W, Fryer JN, Tran TN, Lederis K. Isolation, Amino-Acid Sequence, Synthesis and Biological Properties of Urotensin I from Hippoglossoides elassodon. Journal of Neuroendocrinology. 2: 875-82. PMID 19215432 DOI: 10.1111/j.1365-2826.1990.tb00654.x  0.524
1990 Cole BJ, Cador M, Stinus L, Rivier J, Vale W, Koob GF, Le Moal M. Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization. Brain Research. 512: 343-6. PMID 2354366 DOI: 10.1016/0006-8993(90)90646-S  0.33
1990 Rivier C, Meunier H, Roberts V, Vale W. Inhibin: role and secretion in the rat. Recent Progress in Hormone Research. 46: 231-57; discussion 2. PMID 2281185 DOI: 10.1016/B978-0-12-571146-3.50013-4  0.584
1990 Cole BJ, Cador M, Stinus L, Rivier C, Rivier J, Vale W, Le Moal M, Koob GF. Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior. Life Sciences. 47: 1715-20. PMID 2250584 DOI: 10.1016/0024-3205(90)90344-Q  0.535
1990 Rivier C, Imaki T, Vale W. Prolonged exposure to alcohol: effect on CRF mRNA levels, and CRF- and stress-induced ACTH secretion in the rat. Brain Research. 520: 1-5. PMID 2169950 DOI: 10.1016/0006-8993(90)91685-A  0.559
1990 Irwin M, Vale W, Rivier C. Central corticotropin-releasing factor mediates the suppressive effect of stress on natural killer cytotoxicity. Endocrinology. 126: 2837-44. PMID 2161737 DOI: 10.1210/endo-126-6-2837  0.552
1990 Young EA, Watson SJ, Kotun J, Haskett RF, Grunhaus L, Murphy-Weinberg V, Vale W, Rivier J, Akil H. Beta-lipotropin-beta-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression. Preliminary studies. Archives of General Psychiatry. 47: 449-57. PMID 2139563 DOI: 10.1001/ARCHPSYC.1990.01810170049008  0.322
1990 Rivier C, Vale W. Cytokines act within the brain to inhibit luteinizing hormone secretion and ovulation in the rat. Endocrinology. 127: 849-56. PMID 2115435 DOI: 10.1210/endo-127-2-849  0.536
1990 Asa SL, Kovacs K, Stefaneanu L, Horvath E, Billestrup N, Gonzalez-Manchon C, Vale W. Pituitary mammosomatotroph adenomas develop in old mice transgenic for growth hormone-releasing hormone. Experimental Biology and Medicine. 193: 232-235. PMID 2106141 DOI: 10.3181/00379727-193-3-Rc1  0.361
1990 Struthers RS, Tanaka G, Koerber SC, Solmajer T, Baniak EL, Gierasch LM, Vale W, Rivier J, Hagler AT. Design of biologically active, conformationally constrained GnRH antagonists Proteins: Structure, Function and Genetics. 8: 295-304. PMID 2091022 DOI: 10.1002/Prot.340080403  0.314
1989 Peterson ME, Palkovits M, Chiueh CC, Graves TK, Mezey E, Vale W, Krieger DT. Biogenic Amine and Corticotrophin-Releasing Factor Concentrations in Hypothalamic Paraventricular Nucleus and Biogenic Amine Levels in the Median Eminence of Normal Dogs, Chronic Dexamethasone-Treated Dogs, and Dogs with Naturally-Occurring Pituitary-Dependent Hyperadrenocorticism (Canine Cushing's Disease). Journal of Neuroendocrinology. 1: 169-171. PMID 19210450 DOI: 10.1111/J.1365-2826.1989.Tb00098.X  0.337
1989 Samson WK, Bianchi R, Mogg RJ, Rivier J, Vale W, Melin P. Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion Endocrinology. 124: 812-819. PMID 2912703 DOI: 10.1210/Endo-124-2-812  0.423
1989 Widmaier EP, Lim AT, Vale W. Secretion of corticotropin-releasing factor from cultured rat hypothalamic cells: effects of catecholamines. Endocrinology. 124: 583-90. PMID 2783568 DOI: 10.1210/Endo-124-2-583  0.433
1989 Kitayama I, Cintra A, Janson AM, Fuxe K, Agnati LF, Eneroth P, Aronsson M, Härfstrand A, Steinbush HWM, Visser TJ, Goldstein M, Vale W, Gustafsson JÅ. Chronic immobilization stress: evidence for decreases of 5-hydroxy-tryptamine immunoreactivity and for increases of glucocorticoid receptor immunoreactivity in various brain regions of the male rat. Journal of Neural Transmission. 77: 93-130. PMID 2760606 DOI: 10.1007/Bf01248925  0.343
1989 Vaughan JM, Rivier J, Corrigan AZ, McClintock R, Campen CA, Jolley D, Voglmayr JK, Bardin CW, Rivier C, Vale W. Detection and purification of inhibin using antisera generated against synthetic peptide fragments. Methods in Enzymology. 168: 588-617. PMID 2725313 DOI: 10.1016/0076-6879(89)68044-5  0.537
1989 Rivier C, Vale W. In the rat, interleukin-1 alpha acts at the level of the brain and the gonads to interfere with gonadotropin and sex steroid secretion. Endocrinology. 124: 2105-9. PMID 2651094 DOI: 10.1210/endo-124-5-2105  0.548
1989 Rivier C, Vale W. Immunoreactive inhibin secretion by the hypophysectomized female rat: demonstration of the modulating effect of gonadotropin-releasing hormone and estrogen through a direct ovarian site of action. Endocrinology. 124: 195-8. PMID 2642415 DOI: 10.1210/endo-124-1-195  0.596
1989 Rivier C, Vale W, Brown M. In the rat, interleukin-1 alpha and -beta stimulate adrenocorticotropin and catecholamine release. Endocrinology. 125: 3096-102. PMID 2573510 DOI: 10.1210/endo-125-6-3096  0.469
1989 Rivier C, Chizzonite R, Vale W. In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology. 125: 2800-5. PMID 2555127 DOI: 10.1210/endo-125-6-2800  0.53
1989 Perrin MH, Haas Y, Porter J, Rivier J, Vale W. The gonadotropin-releasing hormone pituitary receptor interacts with a guanosine triphosphate-binding protein: differential effects of guanyl nucleotides on agonist and antagonist binding. Endocrinology. 124: 798-804. PMID 2536322 DOI: 10.1210/endo-124-2-798  0.341
1989 Roberts V, Meunier H, Vaughan J, Rivier J, Rivier C, Vale W, Sawchenko P. Production and regulation of inhibin subunits in pituitary gonadotropes. Endocrinology. 124: 552-4. PMID 2535814 DOI: 10.1210/Endo-124-1-552  0.547
1989 Carroll RS, Corrigan AZ, Gharib SD, Vale W, Chin WW. Inhibin, Activin, and Follistatin: Regulation of Follicle-Stimulating Hormone Messenger Ribonucleic Acid Levels Molecular Endocrinology. 3: 1969-1976. PMID 2516876 DOI: 10.1210/Mend-3-12-1969  0.307
1989 Nemeroff CB, Krishnan KR, Belkin BM, Ritchie JC, Clark C, Vale WW, Rivier JE, Thorner MO. Growth hormone response to growth hormone releasing factor in Alzheimer's disease. Neuroendocrinology. 50: 663-6. PMID 2515465 DOI: 10.1159/000125296  0.373
1989 Stefaneanu L, Kovacs K, Horvath E, Asa SL, Losinski NE, Billestrup N, Price J, Vale W. Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation. Endocrinology. 125: 2710-2718. PMID 2507296 DOI: 10.1210/Endo-125-5-2710  0.349
1989 Rivier C, Roberts V, Vale W. Possible role of luteinizing hormone and follicle-stimulating hormone in modulating inhibin secretion and expression during the estrous cycle of the rat. Endocrinology. 125: 876-82. PMID 2502378 DOI: 10.1210/endo-125-2-876  0.577
1989 Rivier C, Vale W. Immunoneutralization of endogenous inhibin modifies hormone secretion and ovulation rate in the rat. Endocrinology. 125: 152-7. PMID 2500324 DOI: 10.1210/endo-125-1-152  0.571
1989 Vance ML, Kaiser DL, Martha PM, Furlanetto R, Rivier J, Vale W, Thorner MO. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy. The Journal of Clinical Endocrinology and Metabolism. 68: 22-8. PMID 2491864 DOI: 10.1210/jcem-68-1-22  0.319
1989 Rivier C, Meunier H, Roberts V, Vale W. Possible involvement of inhibin in altered follicle-stimulating hormone (FSH) secretion during dissociated luteinizing hormone (LH) and FSH release: unilateral castration and experimental cryptorchidism. Biology of Reproduction. 41: 967-81. PMID 2483127 DOI: 10.1095/Biolreprod41.5.967  0.549
1989 Nahon JL, Presse F, Bittencourt JC, Sawchenko PE, Vale W. The rat melanin-concentrating hormone messenger ribonucleic acid encodes multiple putative neuropeptides coexpressed in the dorsolateral hypothalamus. Endocrinology. 125: 2056-65. PMID 2477226 DOI: 10.1210/Endo-125-4-2056  0.364
1988 Sapolsky RM, Packan DR, Vale WW. Glucocorticoid toxicity in the hippocampus: in vitro demonstration. Brain Research. 453: 367-71. PMID 3401775 DOI: 10.1016/0006-8993(88)90180-1  0.403
1988 Rivier J, Kupryszewski G, Varga J, Porter J, Rivier C, Perrin M, Hagler A, Struthers S, Corrigan A, Vale W. Design of potent cyclic gonadotropin releasing hormone antagonists. Journal of Medicinal Chemistry. 31: 677-82. PMID 3279211 DOI: 10.1021/Jm00398A030  0.535
1988 Meunier H, Cajander SB, Roberts VJ, Rivier C, Sawchenko PE, Hsueh AJ, Vale W. Rapid changes in the expression of inhibin alpha-, beta A-, and beta B-subunits in ovarian cell types during the rat estrous cycle. Molecular Endocrinology (Baltimore, Md.). 2: 1352-63. PMID 3146021 DOI: 10.1210/Mend-2-12-1352  0.503
1988 Hall JE, Brodie TD, Badger TM, Rivier J, Vale W, Conn PM, Schoenfeld D, Crowley WF. Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist. The Journal of Clinical Endocrinology and Metabolism. 67: 524-31. PMID 3137243 DOI: 10.1210/Jcem-67-3-524  0.384
1988 Rivier J, Rivier C, Galyean R, Yammamoto G, Vale W. Potent long-acting growth hormone releasing factor analogues. Annals of the New York Academy of Sciences. 527: 44-50. PMID 3133968 DOI: 10.1111/j.1749-6632.1988.tb26971.x  0.563
1988 Rivier C, Cajander S, Vaughan J, Hsueh AJ, Vale W. Age-dependent changes in physiological action, content, and immunostaining of inhibin in male rats. Endocrinology. 123: 120-6. PMID 3133192 DOI: 10.1210/endo-123-1-120  0.535
1988 Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T, Vaughan J, Corrigan A, Bardin W, Sawchenko P. Chemical and biological characterization of the inhibin family of protein hormones. Recent Progress in Hormone Research. 44: 1-34. PMID 3064204 DOI: 10.1016/B978-0-12-571144-9.50005-3  0.554
1988 Vaccarino FJ, Feifel D, Rivier J, Vale W, Koob GF. Centrally administered hypothalamic growth hormone-releasing factor stimulates food intake in free-feeding rats. Peptides. 9: 35-8. PMID 2856650 DOI: 10.1016/0196-9781(88)90220-3  0.326
1988 Rivier C, Vale W. Interaction between ethanol and stress on ACTH and beta-endorphin secretion. Alcoholism, Clinical and Experimental Research. 12: 206-10. PMID 2837103 DOI: 10.1111/J.1530-0277.1988.Tb00181.X  0.582
1988 Meunier H, Rivier C, Evans RM, Vale W. Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions. Proceedings of the National Academy of Sciences of the United States of America. 85: 247-51. PMID 2829170 DOI: 10.1073/Pnas.85.1.247  0.508
1988 Krishnan KR, Manepalli AN, Ritchie JC, Rayasam K, Melville ML, Daughtry G, Thorner MO, Rivier JE, Vale WW, Nemeroff CB. Growth hormone-releasing factor stimulation test in depression. The American Journal of Psychiatry. 145: 90-2. PMID 2827532 DOI: 10.1176/AJP.145.1.90  0.378
1987 Rivier C, Vale W. Diminished responsiveness of the hypothalamic-pituitary-adrenal axis of the rat during exposure to prolonged stress: a pituitary-mediated mechanism. Endocrinology. 121: 1320-8. PMID 3498626 DOI: 10.1210/endo-121-4-1320  0.57
1987 Tazi A, Dantzer R, Le Moal M, Rivier J, Vale W, Koob GF. Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats. Regulatory Peptides. 18: 37-42. PMID 3498188 DOI: 10.1016/0167-0115(87)90048-6  0.359
1987 Petraglia F, Lim AT, Vale W. Adenosine 3',5'-monophosphate, prostaglandins, and epinephrine stimulate the secretion of immunoreactive gonadotropin-releasing hormone from cultured human placental cells. The Journal of Clinical Endocrinology and Metabolism. 65: 1020-5. PMID 3312277 DOI: 10.1210/jcem-65-5-1020  0.37
1987 Petraglia F, Sawchenko P, Lim AT, Rivier J, Vale W. Localization, secretion, and action of inhibin in human placenta. Science (New York, N.Y.). 237: 187-9. PMID 3299703 DOI: 10.1126/Science.3299703  0.393
1987 Rivier C, Vale W, Rivier J. Studies of the inhibin family of hormones: a review. Hormone Research. 28: 104-18. PMID 3136065 DOI: 10.1159/000180934  0.544
1987 Billestrup N, Mitchell RL, Vale W, Verma IM. Growth hormone-releasing factor induces c-fos expression in cultured primary pituitary cells. Molecular Endocrinology (Baltimore, Md.). 1: 300-5. PMID 3135482 DOI: 10.1210/Mend-1-4-300  0.353
1987 Rivier C, Rivier J, Vale W. Inhibin: measurement and role in the rat. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 14: 273-6. PMID 3115918 DOI: 10.1016/0883-2897(87)90002-X  0.499
1987 Cintra A, Fuxe K, Härfstrand A, Agnati LF, Wikström AC, Okret S, Vale W, Gustafsson JÅ. Presence of glucocorticoid receptor immunoreactivity in corticotrophin releasing factor and in growth hormone releasing factor immunoreactive neurons of the rat di- and telencephalon Neuroscience Letters. 77: 25-30. PMID 3110702 DOI: 10.1016/0304-3940(87)90601-X  0.373
1987 Rivier C, Vale W. Inhibin: measurement and role in the immature female rat. Endocrinology. 120: 1688-90. PMID 3104016 DOI: 10.1210/endo-120-4-1688  0.522
1987 Petraglia F, Sawchenko PE, Rivier J, Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature. 328: 717-9. PMID 3039377 DOI: 10.1038/328717A0  0.416
1987 Bicsak TA, Vale W, Vaughan J, Tucker EM, Cappel S, Hsueh AJ. Hormonal regulation of inhibin production by cultured Sertoli cells. Molecular and Cellular Endocrinology. 49: 211-7. PMID 3030853 DOI: 10.1016/0303-7207(87)90215-2  0.371
1987 Zukin SR, Zukin RS, Vale W, Rivier J, Nichtenhauser R, Snell LD, Johnson KM. An endogenous ligand of the brain sigma/PCP receptor antagonizes NMDA-induced neurotransmitter release. Brain Research. 416: 84-9. PMID 2887250 DOI: 10.1016/0006-8993(87)91499-5  0.358
1987 Petraglia F, Vale W, Rivier C. Beta-endorphin and dynorphin participate in the stress-induced release of prolactin in the rat. Neuroendocrinology. 45: 338-42. PMID 2884585 DOI: 10.1159/000124756  0.546
1987 Rivier C, Vale W. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Research. 422: 403-6. PMID 2823980 DOI: 10.1016/0006-8993(87)90953-X  0.542
1987 Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science (New York, N.Y.). 238: 522-4. PMID 2821621 DOI: 10.1126/science.2821621  0.647
1987 Biffignandi P, Molinatti GM, Zoppi S, Cocconi M, Serio M, Martini L, Motta M, Pugeat M, Lejeune H, Dechaud H, Emptoz-Bonneton A, Fleury M, Charrié A, Tourniaire J, Forest MG, ... ... Vale W, et al. Subject Index, Vol. 28, 1987 Hormone Research in Paediatrics. 28: 291-292. DOI: 10.1159/000180955  0.425
1987 Biffignandi P, Molinatti GM, Zoppi S, Cocconi M, Serio M, Martini L, Motta M, Pugeat M, Lejeune H, Dechaud H, Emptoz-Bonneton A, Fleury M, Charrié A, Tourniaire J, Forest MG, ... ... Vale W, et al. Contents, Vol. 28, 1987 Hormone Research in Paediatrics. 28. DOI: 10.1159/000180929  0.435
1987 Rivier J, Rivier C, Perrin M, Hagler A, Struthers S, Pandol S, Brown M, Kupryszewski G, Chadhuri M, Vale W. Competitive antagonists of peptide hormones Regulatory Peptides. 19: 135. DOI: 10.1016/0167-0115(87)90147-9  0.525
1986 Fuxe K, Andersson K, Härfstrand A, Agnati LF, Eneroth P, Janson AM, Vale W, Thorner M, Goldstein M. Medianosomes as integrative units in the external layer of the median eminence. Studies on grf/catecholamine and somatostatin/catecholamine interactions in the hypothalamus of the male rat. Neurochemistry International. 9: 155-70. PMID 20493113 DOI: 10.1016/0197-0186(86)90044-6  0.381
1986 Thorner MO, Vance ML, Evans WS, Rogol AD, Rivier J, Vale W, Blizzard RM. Clinical studies with ghrh in man Hormone Research in Paediatrics. 24: 91-98. PMID 3093355 DOI: 10.1159/000180547  0.335
1986 Wehrenberg WB, Esch F, Baird A, Ying S-, Bölen P, Ling N, Thorner MO, Zapf J, Froesch ER, Brande JLVd, Jansen M, Hoogerbrugge CM, Pagter-Holthuizen Pd, Buul-Offers SCv, Schaik FMAv, ... ... Vale W, et al. Therapeutic Agents Produced by Genetic Engineering: Quo Vadis? The Example of Growth Hormone and Its Releasing Factor Hormone Research in Paediatrics. 24: 201-228. PMID 3093353 DOI: 10.1159/000180560  0.316
1986 Thorner MO, Vance ML, Evans WS, Ho K, Rogol AD, Blizzard RM, Furlanetto R, Rivier J, Vale W. Growth hormone releasing factor and somatomedin C production: extrahypothalamic localization and possible functional significance. Acta Endocrinologica. Supplementum. 276: 34-40. PMID 3092530 DOI: 10.1530/ACTA.0.111S0034  0.383
1986 Rivier C, Rivier J, Vale W. Inhibin-mediated feedback control of follicle-stimulating hormone secretion in the female rat. Science (New York, N.Y.). 234: 205-8. PMID 3092356 DOI: 10.1126/Science.3092356  0.587
1986 Vance ML, Kaiser DL, Rivier J, Vale W, Thorner MO. Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH. The Journal of Clinical Endocrinology and Metabolism. 62: 591-4. PMID 3080467 DOI: 10.1210/jcem-62-3-591  0.369
1986 Bicsak TA, Tucker EM, Cappel S, Vaughan J, Rivier J, Vale W, Hsueh AJ. Hormonal regulation of granulosa cell inhibin biosynthesis. Endocrinology. 119: 2711-9. PMID 3023019 DOI: 10.1210/endo-119-6-2711  0.406
1986 Walker CD, Sapolsky RM, Meaney MJ, Vale WW, Rivier CL. Increased pituitary sensitivity to glucocorticoid feedback during the stress nonresponsive period in the neonatal rat. Endocrinology. 119: 1816-21. PMID 3019645 DOI: 10.1210/endo-119-4-1816  0.627
1986 Billestrup N, Swanson LW, Vale W. Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proceedings of the National Academy of Sciences of the United States of America. 83: 6854-7. PMID 3018748 DOI: 10.1073/Pnas.83.18.6854  0.365
1986 Mayo KE, Cerelli GM, Spiess J, Rivier J, Rosenfeld MG, Evans RM, Vale W. Inhibin A-subunit cDNAs from porcine ovary and human placenta Proceedings of the National Academy of Sciences of the United States of America. 83: 5849-5853. PMID 3016724 DOI: 10.1073/Pnas.83.16.5849  0.592
1986 Britton KT, Lee G, Vale W, Rivier J, Koob GF. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat. Brain Research. 369: 303-6. PMID 3008937 DOI: 10.1016/0006-8993(86)90539-1  0.399
1986 Walker CD, Perrin M, Vale W, Rivier C. Ontogeny of the stress response in the rat: role of the pituitary and the hypothalamus. Endocrinology. 118: 1445-51. PMID 3004915 DOI: 10.1210/endo-118-4-1445  0.558
1986 Rivier C, Rivier J, Vale W. Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science (New York, N.Y.). 231: 607-9. PMID 3003907 DOI: 10.1126/Science.3003907  0.593
1986 Petraglia F, Vale W, Rivier C. Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat. Endocrinology. 119: 2445-50. PMID 2877862 DOI: 10.1210/endo-119-6-2445  0.564
1986 Rivier JE, Porter J, Rivier CL, Perrin M, Corrigan A, Hook WA, Siraganian RP, Vale WW. New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro. Journal of Medicinal Chemistry. 29: 1846-51. PMID 2428978  0.544
1986 Norman RL, Rivier J, Vale W, Spies HG. Inhibition of estradiol-induced gonadotropin release in ovariectomized rhesus macaques by a gonadotropin-releasing hormone antagonist. Fertility and Sterility. 45: 288-291. DOI: 10.1016/S0015-0282(16)49169-7  0.398
1985 Rivier J, Spiess J, McClintock R, Vaughan J, Vale W. Purification and partial characterization of inhibin from porcine follicular fluid Biochemical and Biophysical Research Communications. 133: 120-127. PMID 4074357 DOI: 10.1016/0006-291X(85)91849-2  0.302
1985 Fuxe K, Wikström A, Okret S, Agnati LF, Härfstrand A, Yu Z, Granholm L, Zoli M, Vale W, Gustafsson J. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology. 117: 1803-1812. PMID 4042964 DOI: 10.1210/Endo-117-5-1803  0.313
1985 Evans WS, Vance ML, Kaiser DL, Sellers RP, Borges JL, Downs TR, Frohman LA, Rivier J, Vale W, Thorner MO. Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal men. The Journal of Clinical Endocrinology and Metabolism. 61: 846-50. PMID 3930551 DOI: 10.1210/jcem-61-5-846  0.36
1985 Britton KT, Morgan J, Rivier J, Vale W, Koob GF. Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test. Psychopharmacology. 86: 170-4. PMID 3927353 DOI: 10.1007/BF00431704  0.346
1985 Styne DM, Harris DA, Egli CA, Conte FA, Kaplan SL, Rivier J, Vale W, Grumbach MM. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis. The Journal of Clinical Endocrinology and Metabolism. 61: 142-51. PMID 3923027 DOI: 10.1210/jcem-61-1-142  0.3
1985 Grady RR, Shin L, Charlesworth MC, Cohen-Becker IR, Smith M, Rivier C, Rivier J, Vale W, Schwartz NB. Differential suppression of follicle-stimulating hormone and luteinizing hormone secretion in vivo by a gonadotropin-releasing hormone antagonist. Neuroendocrinology. 40: 246-52. PMID 3921860 DOI: 10.1159/000124081  0.516
1985 Schwartz NB, Rivier C, Rivier J, Vale WW. Effect of gonadotropin-releasing hormone antagonists on serum follicle-stimulating hormone and luteinizing hormone under conditions of singular follicle-stimulating hormone secretion. Biology of Reproduction. 32: 391-8. PMID 3921074 DOI: 10.1095/Biolreprod32.2.391  0.513
1985 Asa SL, Kovacs K, Thorner MO, Leong DA, Rivier J, Vale W. Immunohistological localization of growth hormone-releasing hormone in human tumors. The Journal of Clinical Endocrinology and Metabolism. 60: 423-427. PMID 3919041 DOI: 10.1210/Jcem-60-3-423  0.304
1985 Vance ML, Kaiser DL, Evans WS, Thorner MO, Furlanetto R, Rivier J, Vale W, Perisutti G, Frohman LA. Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man. The Journal of Clinical Endocrinology and Metabolism. 60: 370-5. PMID 3917460 DOI: 10.1210/jcem-60-2-370  0.361
1985 Thorner MO, Reschke J, Chitwood J, Rogol AD, Furlanetto R, Rivier J, Vale W, Blizzard RM. Acceleration of growth in two children treated with human growth hormone-releasing factor. The New England Journal of Medicine. 312: 4-9. PMID 3917299 DOI: 10.1056/NEJM198501033120102  0.324
1985 Eaves M, Thatcher-Britton K, Rivier J, Vale W, Koob GF. Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats Peptides. 6: 923-926. PMID 3878503 DOI: 10.1016/0196-9781(85)90323-7  0.405
1985 Agnati LF, Fuxe K, Yu Z, Härfstrand A, Okret S, Wikström A, Goldstein M, Zoli M, Vale W, Gustafsson JA. Morphometrical analysis of the distribution of corticotrophin releasing factor, glucocorticoid receptor and phenylethanolamine-N-methyltransferase immunoreactive structures in the paraventricular hypothalamic nucleus of the rat. Neuroscience Letters. 54: 147-152. PMID 3873028 DOI: 10.1016/S0304-3940(85)80070-7  0.332
1985 De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 5: 3189-203. PMID 3001239 DOI: 10.1523/Jneurosci.05-12-03189.1985  0.351
1985 De Souza EB, Perrin MH, Whitehouse PJ, Rivier J, Vale W, Kuhar MJ. Corticotropin-releasing factor receptors in human pituitary gland: autoradiographic localization. Neuroendocrinology. 40: 419-22. PMID 2989722 DOI: 10.1159/000124107  0.374
1985 Rivier C, Vale W. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat. The Journal of Clinical Investigation. 75: 689-94. PMID 2982917 DOI: 10.1172/JCI111748  0.551
1985 Rivier C, Vale W. Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat. Endocrinology. 117: 2478-82. PMID 2866087 DOI: 10.1210/endo-117-6-2478  0.598
1985 Vance ML, Kaiser DL, Evans WS, Furlanetto R, Vale W, Rivier J, Thorner MO. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion. The Journal of Clinical Investigation. 75: 1584-90. PMID 2860126 DOI: 10.1172/JCI111864  0.379
1985 Rivier J, Pandol S, Perrin M, Seifert H, Galyean R, Yamamoto G, Rivier C, Vale W. Invited speakers' abstractConformationally altered fragments of rat GRF: VIP homologs, analogs or both? Regulatory Peptides. 10. DOI: 10.1016/0167-0115(85)90297-6  0.513
1984 Rivier C, Vale W. Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat. Endocrinology. 114: 2409-11. PMID 6609812 DOI: 10.1210/endo-114-6-2409  0.593
1984 Sawchenko PE, Swanson LW, Vale WW. Corticotropin-releasing factor: co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the male rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 4: 1118-29. PMID 6609226 DOI: 10.1523/Jneurosci.04-04-01118.1984  0.33
1984 Evans WS, Borges JL, Vance ML, Kaiser DL, Rogol AD, Furlanetto R, Rivier J, Vale W, Thorner MO. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle. The Journal of Clinical Endocrinology and Metabolism. 59: 1006-10. PMID 6434583 DOI: 10.1210/jcem-59-5-1006  0.348
1984 Charlesworth MC, Grady RR, Shin L, Vale WW, Rivier C, Rivier J, Schwartz NB. Differential suppression of FSH and LH secretion by follicular fluid in the presence or absence of GnRH. Neuroendocrinology. 38: 199-205. PMID 6425710 DOI: 10.1159/000123891  0.518
1984 Nemeroff CB, Widerlöv E, Bissette G, Walléus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science (New York, N.Y.). 226: 1342-4. PMID 6334362 DOI: 10.1126/Science.6334362  0.441
1984 Bruhn TO, Sutton RE, Rivier CL, Vale WW. Corticotropin-releasing factor regulates proopiomelanocortin messenger ribonucleic acid levels in vivo. Neuroendocrinology. 39: 170-5. PMID 6332279  0.523
1984 De Souza EB, Perrin MH, Insel TR, Rivier J, Vale WW, Kuhar MJ. Corticotropin-releasing factor receptors in rat forebrain: autoradiographic identification. Science (New York, N.Y.). 224: 1449-51. PMID 6328656 DOI: 10.1126/Science.6328656  0.403
1984 Carey RM, Varma SK, Drake CR, Thorner MO, Kovacs K, Rivier J, Vale W. Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study. The New England Journal of Medicine. 311: 13-20. PMID 6328303 DOI: 10.1056/Nejm198407053110103  0.382
1984 Rivier J, Rivier C, Vale W. Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science (New York, N.Y.). 224: 889-91. PMID 6326264 DOI: 10.1126/Science.6326264  0.562
1984 De Souza EB, Perrin MH, Rivier J, Vale WW, Kuhar MJ. Corticotropin-releasing factor receptors in rat pituitary gland: autoradiographic localization. Brain Research. 296: 202-7. PMID 6324957 DOI: 10.1016/0006-8993(84)90534-1  0.309
1984 Rivier C, Vale W. Influence of corticotropin-releasing factor on reproductive functions in the rat. Endocrinology. 114: 914-21. PMID 6321146 DOI: 10.1210/endo-114-3-914  0.602
1984 Pandol SJ, Seifert H, Thomas MW, Rivier J, Vale W. Growth hormone-releasing factor stimulates pancreatic enzyme secretion Science. 225: 326-328. PMID 6204379 DOI: 10.1126/science.6204379  0.375
1984 Brown MR, Rivier C, Vale W. Central nervous system regulation of adrenocorticotropin secretion: role of somatostatins. Endocrinology. 114: 1546-9. PMID 6143656 DOI: 10.1210/endo-114-5-1546  0.582
1984 Koob GF, Swerdlow N, Seeligson M, Eaves M, Sutton R, Rivier J, Vale W. Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation Neuroendocrinology. 39: 450-464. PMID 6096752 DOI: 10.1159/000124021  0.322
1984 Rivier C, Rivier J, Mormede P, Vale W. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat. Endocrinology. 115: 882-6. PMID 6086290 DOI: 10.1210/endo-115-3-882  0.572
1984 MANSFIELD MJ, BEARDSWORTH DE, LOUGHLIN JS, CRAWFORD JD, BODE HH, RIVIER J, VALE W, KUSHNER DC, CRIGLER JF, CROWLEY WF. Long-Term Treatment of Central Precocious Puberty with a Long-Acting Analogue of Luteinizing Hormone-Releasing Hormone. Effects on Somatic Growth and Skeletal Maturation Obstetrical & Gynecological Survey. 39: 591-592. DOI: 10.1097/00006254-198409000-00017  0.337
1983 Ehlers CL, Henriksen SJ, Wang M, Rivier J, Vale W, Bloom FE. Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Research. 278: 332-6. PMID 6605787 DOI: 10.1016/0006-8993(83)90266-4  0.373
1983 Rivier J, Spiess J, Vale W. Characterization of rat hypothalamic corticotropin-releasing factor. Proceedings of the National Academy of Sciences of the United States of America. 80: 4851-4855. PMID 6603620 DOI: 10.1073/Pnas.80.15.4851  0.645
1983 Mayo KE, Vale W, Rivier J, Rosenfeld MG, Evans RM. Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor Nature. 306: 86-88. PMID 6415488 DOI: 10.1038/306086a0  0.369
1983 Barinaga M, Yamonoto G, Rivier C, Vale W, Evans R, Rosenfeld MG. Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor. Nature. 306: 84-5. PMID 6415487 DOI: 10.1038/306084A0  0.571
1983 Arimura A, Culler MD, Turkelson CM, Luciano MG, Thomas CR, Obara N, Groot K, Rivier J, Vale W. In vitro pituitary hormone releasing activity of 40 residue human pancreatic tumor growth hormone releasing factor. Peptides. 4: 107-10. PMID 6408622 DOI: 10.1016/0196-9781(83)90175-4  0.382
1983 Filicori M, Hall DA, Loughlin JS, Rivier J, Vale W, Crowley WF. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. American Journal of Obstetrics and Gynecology. 147: 726-7. PMID 6356927 DOI: 10.1016/0002-9378(83)90463-5  0.343
1983 Rivier C, Vale W, Rivier J. Effects of gonadotropin releasing hormone agonists and antagonists on reproductive functions. Journal of Medicinal Chemistry. 26: 1545-50. PMID 6355476 DOI: 10.1021/JM00365A001  0.566
1983 Spiess J, Rivier J, Vale W. Sequence analysis of rat hypothalamic corticotropin-releasing factor with the o-phthalaldehyde strategy. Biochemistry. 22: 4341-4346. PMID 6354254 DOI: 10.1021/Bi00287A027  0.619
1983 Rivier C, Vale W. Influence of ethanol on reproductive functions of the adult male rat as a function of body weight. Alcoholism, Clinical and Experimental Research. 7: 210-2. PMID 6346925 DOI: 10.1111/J.1530-0277.1983.Tb05443.X  0.5
1983 Sherwood N, Eiden L, Brownstein M, Spiess J, Rivier J, Vale W. Characterization of a teleost gonadotropin-releasing hormone. Proceedings of the National Academy of Sciences of the United States of America. 80: 2794-8. PMID 6341999 DOI: 10.1073/Pnas.80.9.2794  0.646
1983 Vale W, Vaughan J, Yamamoto G, Bruhn T, Douglas C, Dalton D, Rivier C, Rivier J. Assay of corticotropin releasing factor. Methods in Enzymology. 103: 565-77. PMID 6321896 DOI: 10.1016/S0076-6879(83)03040-2  0.541
1983 Rivier C, Vale W. Effect of angiotensin II on ACTH release in vivo: role of corticotropin-releasing factor. Regulatory Peptides. 7: 253-8. PMID 6320315 DOI: 10.1016/0167-0115(83)90018-6  0.547
1983 Rivier C, Rivier J, Perrin M, Vale W. Comparison of the effect of several gonadotropin releasing hormone antagonists on luteinizing hormone secretion, receptor binding and ovulation. Biology of Reproduction. 29: 374-8. PMID 6315093 DOI: 10.1095/Biolreprod29.2.374  0.605
1983 Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson L, Bilezikjian L, Bloom F, Rivier J. Chemical and biological characterization of corticotropin releasing factor. Recent Progress in Hormone Research. 39: 245-70. PMID 6314446 DOI: 10.1016/B978-0-12-571139-5.50010-0  0.571
1983 Rivier C, Vale W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature. 305: 325-7. PMID 6312319 DOI: 10.1038/305325a0  0.574
1983 Rivier C, Vale W. Influence of the frequency of ovine corticotropin-releasing factor administration on adrenocorticotropin and corticosterone secretion in the rat. Endocrinology. 113: 1422-6. PMID 6311521 DOI: 10.1210/endo-113-4-1422  0.593
1983 Rivier C, Vale W. Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology. 113: 939-42. PMID 6307672 DOI: 10.1210/endo-113-3-939  0.598
1983 Donald RA, Redekopp C, Cameron V, Nicholls MG, Bolton J, Livesey J, Espiner EA, Rivier J, Vale W. The hormonal actions of corticotropin-releasing factor in sheep: Effect of intravenous and intracerebroventricular injection Endocrinology. 113: 866-870. PMID 6307669 DOI: 10.1210/Endo-113-3-866  0.4
1983 Vale W, Vaughan J, Smith M, Yamamoto G, Rivier J, Rivier C. Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells. Endocrinology. 113: 1121-31. PMID 6307665 DOI: 10.1210/endo-113-3-1121  0.574
1983 Rivier C, Rivier J, Lederis K, Vale W. In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I. Regulatory Peptides. 5: 139-43. PMID 6298906 DOI: 10.1016/0167-0115(83)90121-0  0.578
1983 Orth DN, Jackson RV, DeCherney GS, DeBold CR, Alexander AN, Island DP, Rivier J, Rivier C, Spiess J, Vale W. Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. The Journal of Clinical Investigation. 71: 587-95. PMID 6298280 DOI: 10.1172/Jci110804  0.546
1983 Borges JL, Blizzard RM, Gelato MC, Furlanetto R, Rogol AD, Evans WS, Vance ML, Kaiser DL, MacLeod RM, Merriam GR, Loriaux DL, Spiess J, Rivier J, Vale W, Thorner MO. Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency. Lancet (London, England). 2: 119-24. PMID 6134978 DOI: 10.1016/S0140-6736(83)90113-7  0.62
1983 Vale W, Rivier C, Brown M, Plotsky P, Swanson L, Bruhn T, Bloom F, Koob G, Spiess J, Thorner M, Rivier. J. CHARACTERIZATION OF CORTICOTROPIN AND GROWTH HORMONE RELEASING FACTOR. Acta Endocrinologica. 104: S10. DOI: 10.1530/acta.0.103s010  0.358
1983 Antoni FA, Palkovits M, Makara GB, Linton EA, Lowry PJ, Kiss JZ, Bugajski J, Gą A, dek, Walker RF, Luine VN, McEwen BS, Wehrenberg WB, Brazeau P, Luben R, ... ... Vale W, et al. Subject Index Vol. 36, 1983 Neuroendocrinology. 36: 495-496. DOI: 10.1159/000123507  0.494
1983 Antoni FA, Palkovits M, Makara GB, Linton EA, Lowry PJ, Kiss JZ, Bugajski J, Gą A, dek, Walker RF, Luine VN, McEwen BS, Wehrenberg WB, Brazeau P, Luben R, ... ... Vale W, et al. Contents, Vol. 36, 1983 Neuroendocrinology. 36. DOI: 10.1159/000123490  0.503
1982 Brown MR, Fisher LA, Spiess J, Rivier C, Rivier J, Vale W. Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology. 111: 928-31. PMID 7049676 DOI: 10.1210/endo-111-3-928  0.57
1982 Rivier C, Vale W. Interaction of gonadotropin-releasing hormone agonist and antagonist with progesterone, prolactin, or human chorionic gonadotropin during pregnancy in the rat. Endocrinology. 110: 347-51. PMID 7035139 DOI: 10.1210/endo-110-2-347  0.577
1982 Rivier J, Rivier C, Spiess J, Vale W. High-performance liquid chromatographic purification of peptide hormones: ovine hypothalamic amunine (corticotropin releasing factor). Analytical Biochemistry. 127: 258-66. PMID 6984596 DOI: 10.1016/0003-2697(82)90170-1  0.547
1982 Sutton RE, Koob GF, Le Moal M, Rivier J, Vale W. Corticotropin releasing factor produces behavioural activation in rats. Nature. 297: 331-3. PMID 6978997 DOI: 10.1038/297331a0  0.391
1982 Fisher LA, Rivier J, Rivier C, Spiess J, Vale W, Brown MR. Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats. Endocrinology. 110: 2222-4. PMID 6978810 DOI: 10.1210/endo-110-6-2222  0.545
1982 Brown MR, Fisher LA, Rivier J, Spiess J, Rivier C, Vale W. Corticotropin-releasing factor: effects on the sympathetic nervous system and oxygen consumption. Life Sciences. 30: 207-10. PMID 6976501 DOI: 10.1016/0024-3205(82)90654-3  0.539
1982 Bloom FE, Battenberg EL, Rivier J, Vale W. Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus. Regulatory Peptides. 4: 43-8. PMID 6750704 DOI: 10.1016/0167-0115(82)90107-0  0.303
1982 Spiess J, Rivier J, Thorner M, Vale W. Sequence analysis of a growth hormone releasing factor from a human pancreatic islet tumor Biochemistry. 21: 6037-6040. PMID 6295453 DOI: 10.1021/Bi00267A002  0.625
1982 Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Vale W, Horvath E, Kovacs K. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. The Journal of Clinical Investigation. 70: 965-77. PMID 6290540 DOI: 10.1172/Jci110708  0.353
1982 Rivier C, Rivier J, Vale W. Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of corticotropin-releasing factor. Science (New York, N.Y.). 218: 377-9. PMID 6289439 DOI: 10.1126/Science.6289439  0.603
1982 Brown MR, Fisher LA, Spiess J, Rivier J, Rivier C, Vale W. Comparison of the biologic actions of corticotropin-releasing factor and sauvagine. Regulatory Peptides. 4: 107-14. PMID 6289384 DOI: 10.1016/0167-0115(82)90101-X  0.551
1982 Doehmer J, Barinaga M, Vale W, Rosenfeld MG, Verma IM, Evans RM. Introduction of rat growth hormone gene into mouse fibroblasts via a retroviral DNA vector: expression and regulation. Proceedings of the National Academy of Sciences of the United States of America. 79: 2268-72. PMID 6285377 DOI: 10.1073/Pnas.79.7.2268  0.344
1982 Britton DR, Rivier C, Shier T, Bloom F, Vale W. In vivo and in vitro effects of tetrahydroisoquinolines and other alkaloids on rat pituitary function. Biochemical Pharmacology. 31: 1205-11. PMID 6284172 DOI: 10.1016/0006-2952(82)90005-3  0.552
1982 Rivier C, Brownstein M, Spiess J, Rivier J, Vale W. In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology. 110: 272-8. PMID 6274623 DOI: 10.1210/endo-110-1-272  0.595
1981 Spiess J, Villarreal J, Vale W. Isolation and sequence analysis of a somatostatin-like polypeptide from ovine hypothalamus. Biochemistry. 20: 1982-1988. PMID 7225368 DOI: 10.1021/Bi00510A038  0.612
1981 Rivier C, Rivier J, Vale W. Effect of a potent GnRH antagonist and testosterone propionate on mating behavior and fertility in the male rat. Endocrinology. 108: 1998-2001. PMID 7215310 DOI: 10.1210/endo-108-5-1998  0.519
1981 Rivier C, Vale W. Temporal relationship between the abortifacient effects of GnRH antagonists and hormonal secretion. Biology of Reproduction. 24: 1061-7. PMID 7023552 DOI: 10.1095/Biolreprod24.5.1061  0.552
1981 Rivier C, Rivier J, Vale W. Antireproductive effects of a potent GnRH antagonist in the female rat. Endocrinology. 108: 1425-30. PMID 7009151 DOI: 10.1210/endo-108-4-1425  0.566
1981 Spiess J, Rivier J, Rivier C, Vale W. Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proceedings of the National Academy of Sciences of the United States of America. 78: 6517-21. PMID 6273874 DOI: 10.1073/Pnas.78.10.6517  0.699
1981 Rivier C, Vale W. Interaction of GnRH agonists, pituitary hormones and corticosteroids on progesterone secretion in the male rat. Life Sciences. 29: 1523-9. PMID 6272044 DOI: 10.1016/0024-3205(81)90252-6  0.594
1981 Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science (New York, N.Y.). 213: 1394-7. PMID 6267699 DOI: 10.1097/00006254-198205000-00013  0.687
1981 Adrian TE, Barnes AJ, Long RG, O'Shaughnessy DJ, Brown MR, Rivier J, Vale W, Blackburn AM, Bloom SR. The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. The Journal of Clinical Endocrinology and Metabolism. 53: 675-81. PMID 6116721 DOI: 10.1210/jcem-53-4-675  0.322
1981 Barnes AJ, Long RG, Adrian TE, Vale W, Brown MR, Rivier JE, Hanley J, Ghatei MA, Sarson DL, Bloom SR. Effect of a long-acting octapeptide analogue of somatostatin on growth hormone and pancreatic and gastrointestinal hormones in man. Clinical Science (London, England : 1979). 61: 653-6. PMID 6116553 DOI: 10.1042/Cs0610653  0.348
1980 Rivier C, Rivier J, Vale W. Antireproductive effects of a potent gonadotropin-releasing hormone antagonist in the male rat. Science (New York, N.Y.). 210: 93-5. PMID 6774418 DOI: 10.1126/Science.6774418  0.576
1980 Nemeroff CB, Bissette G, Martin JB, Brazeau P, Vale W, Kizer JS, Prange AJ. Effect of chronic treatment with thyrotropin-releasing hormone (TRH) or an analog of TRH (linear beta-alanine TRH) on the hypothalamic-pituitary-thyroid axis. Neuroendocrinology. 30: 193-9. PMID 6769064 DOI: 10.1159/000123000  0.397
1980 Crowley WF, Beitins IZ, Vale W, Kliman B, Rivier J, Rivier C, McArthur JW. The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men. The New England Journal of Medicine. 302: 1052-7. PMID 6767977 DOI: 10.1056/NEJM198005083021903  0.56
1980 Spiess J, Vale W. Multiple forms of somatostatin-like activity in rat hypothalamus. Biochemistry. 19: 2861-2866. PMID 6104982 DOI: 10.1021/Bi00554A007  0.606
1979 Rivier C, Vale W. Hormonal secretion in male rats chronically treated with [D-Trp6, Pro9-NEt]-LRF. Life Sciences. 25: 1065-74. PMID 390282 DOI: 10.1016/0024-3205(79)90592-7  0.551
1979 Rivier C, Rivier J, Vale W. Chronic effects of [D-Trp6,Pro9-NEt]luteinizing hormone-releasing factor on reproductive processes in the male rat. Endocrinology. 105: 1191-201. PMID 385303 DOI: 10.1210/endo-105-5-1191  0.499
1979 Rivier C, Rivier J, Vale W. Effect of the LRF-antagonist [D-pGlu1, D-Phe2, D-Trp3,6]-LRF on pregnancy in the rat. Contraception. 19: 185-90. PMID 371912 DOI: 10.1016/S0010-7824(79)80030-X  0.474
1979 Spiess J, Rivier JE, Rodkey JA, Bennett CD, Vale W. Isolation and characterization of somatostatin from pigeon pancreas Proceedings of the National Academy of Sciences of the United States of America. 76: 2974-2978. PMID 288081 DOI: 10.1073/Pnas.76.6.2974  0.582
1979 Long RG, Barnes AJ, Adrian TE, Mallinson CN, Brown MR, Vale W, Rivier JE, Christofides ND, Bloom SR. Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (London, England). 2: 764-7. PMID 90860 DOI: 10.1016/S0140-6736(79)92115-9  0.331
1978 Vale W, Rivier C, Brown M, Leppaluoto J, Ling N, Monahan M, Rivier J. Pharmacology of hypothalamic regulatory peptides. Clinical Endocrinology. 261S-273S. PMID 829923 DOI: 10.1111/j.1365-2265.1976.tb03834.x  0.499
1978 Rivier C, Rivier J, Vale W. The effect of bombesin and related peptides on prolactin and growth hormone secretion in the rat Endocrinology. 102: 519-522. PMID 743973 DOI: 10.1210/Endo-102-2-519  0.579
1978 Iversen LL, Iversen SD, Bloom F, Douglas C, Brown M, Vale W. Calcium-dependent release of somatostatin and neurotensin from rat brain in vitro. Nature. 273: 161-3. PMID 643079 DOI: 10.1038/273161a0  0.367
1978 Rivier C, Rivier J, Vale W. Chronic effects of [D-Trp6-Pro9-NEt]luteinizing hormone-releasing factor on reproductive processes in the female rat. Endocrinology. 103: 2299-305. PMID 371955 DOI: 10.1210/endo-103-6-2299  0.547
1978 Vale W, Rivier C, Yang L, Minick S, Guillemin R. Effects of purified hypothalamic corticotropin-releasing factor and other substances on the secretion of adrenocorticotropin and beta-endorphin-like immunoactivities in vitro. Endocrinology. 103: 1910-5. PMID 218793 DOI: 10.1210/endo-103-5-1910  0.654
1978 Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F. β-ENDORPHIN AND ADRENOCORTICOTROPIN ARE SECRETED CONCOMITANTLY BY THE PITUITARY GLAND Obstetrical & Gynecological Survey. 33: 184-185. DOI: 10.1097/00006254-197803000-00017  0.684
1977 Vale W, Ling N, Rivier J, Villarreal J, Rivier C, Douglas C, Brown M. Anatomic and phylogenetic distribution of somatostatin. Metabolism: Clinical and Experimental. 25: 1491-4. PMID 979655 DOI: 10.1016/S0026-0495(76)80175-8  0.451
1977 Vale W, Rivier C, Brown M, Rivier J. Pharmacology of thyrotropin releasing factor (TRF), luteinizing hormone releasing factor (LRF), and somatostatin Advances in Experimental Medicine and Biology. 87: 123-156. PMID 409110 DOI: 10.1007/978-1-4615-8849-8_7  0.539
1977 Rivier C, Vale W. Effects of γ aminobutyric acid and histamine on prolactin secretion in the rat Endocrinology. 101: 506-511. PMID 407071 DOI: 10.1210/Endo-101-2-506  0.56
1977 Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F. beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. Science (New York, N.Y.). 197: 1367-9. PMID 197601 DOI: 10.1126/Science.197601  0.709
1977 Rivier C, Vale W, Ling N, Brown M, Guillemin R. Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin. Endocrinology. 100: 238-41. PMID 187406 DOI: 10.1210/endo-100-1-238  0.641
1977 Rivier C, Brown M, Vale W. Effect of neurotensin, substance P and morphine sulfate on the secretion of prolactin and growth hormone in the rat Endocrinology. 100: 751-754. PMID 95701 DOI: 10.1210/Endo-100-3-751  0.551
1976 Orci L, Baetens O, Rufener C, Brown M, Vale W, Guillemin R. Evidence for immunoreactive neurotensin in dog intestinal mucosa. Life Sciences. 19: 559-61. PMID 785139 DOI: 10.1016/0024-3205(76)90236-8  0.473
1976 Villarreal JA, Vale W, Brown M, Butcher M, Brazeau P, Rivier C, Burgus R. Myelin basic protein: a substance that releases immunoreactive growth hormone in vitro. Biochemical and Biophysical Research Communications. 70: 551-8. PMID 59596 DOI: 10.1016/0006-291X(76)91082-2  0.545
1975 Vale W, Brazeau P, Rivier C, Brown M, Boss B, Rivier J, Burgus R, Ling N, Guillemin R. Somatostatin. Recent Progress in Hormone Research. 31: 365-97. PMID 1105719  0.569
1975 Ling N, Vale W. Analogs of luteinizing hormone releasing factor (LRF) synthesis and biological activity of [(Nα-Me)Leu7]LRF and [D-Ala6,(Nα-Me)Leu7]LRF Biochemical and Biophysical Research Communications. 63: 801-806. PMID 1093545 DOI: 10.1016/S0006-291X(75)80454-2  0.31
1975 Rivier J, Brazeau P, Vale W, Guillemin R. Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity. Journal of Medicinal Chemistry. 18: 123-6. PMID 1091734 DOI: 10.1002/Chin.197524427  0.473
1975 Brown M, Rivier J, Vale W, Guillemin R. Variability of the duration of inhibition of growth hormone release by Nalpha-acylated-des-(Ala1-Gly2)-H2somatostatin analogs. Biochemical and Biophysical Research Communications. 65: 752-6. PMID 807218 DOI: 10.1016/S0006-291X(75)80209-9  0.473
1974 Brazeau P, Rivier J, Vale W, Guillemin R. Inhibition of growth hormone secretion in the rat by synthetic somatostatin. Endocrinology. 94: 184-7. PMID 4808882 DOI: 10.1210/endo-94-1-184  0.473
1974 Brazeau P, Vale W, Burgus R, Guillemin R. Isolation of somatostatin (a somatotropin release inhibiting factor) of ovine hypothalamic origin. Canadian Journal of Biochemistry. 52: 1067-72. PMID 4609582  0.401
1974 Brazeau P, Vale W, Rivier J, Guillemin R. Acylated des-(Ala1-Gly2)-somatostatin analogs: prolonged inhibition of growth hormone secretion. Biochemical and Biophysical Research Communications. 60: 1202-7. PMID 4607622 DOI: 10.1016/0006-291X(74)90326-X  0.473
1974 Rivier J, Amoss M, Rivier C, Vale W. Synthetic luteinizing hormone releasing factor. Short chain analogs Journal of Medicinal Chemistry. 17: 230-233. PMID 4588276 DOI: 10.1002/Chin.197425447  0.548
1974 Brazeau P, Vale W, Rivier J, Guillemin R. Biological potency of synthetic somatostatin in the oxidized and reduced form on the inhibition of secretion of growth hormone. Life Sciences. 15: 351-7. PMID 4549923 DOI: 10.1016/0024-3205(74)90225-2  0.473
1974 Rivier C, Vale W. In vivo stimulation of prolactin secretion in the rat by thyrotropin releasing factor, related peptides and hypothalamic extracts Endocrinology. 95: 978-983. PMID 4213178 DOI: 10.1210/Endo-95-4-978  0.595
1974 Vale W, Rivier C, Brazeau P, Guillemin R. Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology. 95: 968-77. PMID 4213073 DOI: 10.1210/endo-95-4-968  0.673
1974 Siler TM, Yen SC, Vale W, Guillemin R. Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor. The Journal of Clinical Endocrinology and Metabolism. 38: 742-5. PMID 4207367 DOI: 10.1210/jcem-38-5-742  0.401
1973 Siler TM, VandenBerg G, Yen SS, Brazeau P, Vale W, Guillemin R. Inhibition of growth hormone release in humans by somatostatin. The Journal of Clinical Endocrinology and Metabolism. 37: 632-4. PMID 4742541 DOI: 10.1210/jcem-37-4-632  0.473
1973 Blackwell R, Vale W, Rivier C, Guillemin R. Effect of perphenazine on the secretion of prolactin in vivo and in vitro. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 142: 68-71. PMID 4683266 DOI: 10.3181/00379727-142-36960  0.664
1973 Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science (New York, N.Y.). 179: 77-9. PMID 4682131 DOI: 10.1126/Science.179.4068.77  0.473
1973 Guillemin R, Amoss M, Blackwell R, Burgus R, Grant G, Ling N, Monahan M, Rivier J, Vale W. Polypeptide antagonists of the hypothalamic luteinizing hormone releasing factors. Journal of Reproduction and Fertility. Supplement. 18: 23-30. PMID 4580254  0.401
1973 Rivier J, Vale W, Burgus R, Ling N, Amoss M, Blackwell R, Guillemin R. Synthetic luteinizing hormone-releasing factor analogs. Series of short-chain amide LRF homologs converging to the amino terminus. Journal of Medicinal Chemistry. 16: 545-9. PMID 4577979 DOI: 10.1021/Jm00263A031  0.473
1973 Blackwell R, Vale W, Amoss M, Burgus R, Monahan M, Rivier J, Ling N, Guillemin R. Lack of effect of native or synthetic LRF on secretion of prolactin in vitro. The American Journal of Physiology. 224: 176-9. PMID 4566850  0.401
1973 Blackwell R, Amoss M, Vale W, Burgus R, Rivier J, Monahan M, Ling N, Guillemin R. Concomitant release of FSH and LH induced by native and synthetic LRF. The American Journal of Physiology. 224: 170-5. PMID 4566849  0.401
1973 Guillemin R, Vale W, Grant G. Chemistry of the hypothalamic releasing factors. Studies on structure-function relationships in TRF and LRF. Voprosy Biokhimii Mozga. 8: 141-76. PMID 4375346  0.401
1973 Vale W, Grant G, Guillemin R. Chemistry of the hypothalamic releasing factors--studies on structure-function relationships. Frontiers in Neuroendocrinology. 375-413. PMID 4369859  0.401
1973 Vale W, Blackwell R, Grant G, Guillemin R. TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro. Endocrinology. 93: 26-33. PMID 4351315 DOI: 10.1210/endo-93-1-26  0.473
1973 Rivier C, Vale W, Guillemin R. An in vivo corticotropin-releasing factor (CRF) assay based on plasma levels of radioimmunoassayable ACTH. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 142: 842-5. PMID 4348096 DOI: 10.3181/00379727-142-37129  0.642
1973 Burgus R, Vale W, Rivier J, Monahan M, Ling N, Grant G, Amoss M, Guillemin R. Chemistry of hypothalamic releasing factors. Progress in Brain Research. 39: 41-51. PMID 4208048 DOI: 10.1016/S0079-6123(08)64065-0  0.473
1973 Rivier J, Brazeau P, Vale W, Ling N, Burgus R, Gilon C, Yardley J, Guillemin R. [Solid-phase total synthesis of a tetradecapeptide having the chemical and biological properties of somatostatine]. Comptes Rendus Hebdomadaires Des SéAnces De L'AcadéMie Des Sciences. SéRie D: Sciences Naturelles. 276: 2737-40. PMID 4198857  0.401
1973 Grant G, Vale W, Guillemin R. Characteristics of the pituitary binding sites for thyrotropin releasing factor. Endocrinology. 92: 1629-33. PMID 4196427 DOI: 10.1210/endo-92-6-1629  0.473
1972 Vale W, Grant G, Amoss M, Blackwell R, Guillemin R. Culture of enzymatically dispersed pituitary cells: functional validation of a method. Endocrinology. 91: 562-72. PMID 4630101 DOI: 10.1210/endo-91-2-562  0.473
1972 Grant G, Vale W, Guillemin R. Interaction of thyrotropin releasing factor with membrane receptors of pituitary cells. Biochemical and Biophysical Research Communications. 46: 28-34. PMID 4621353 DOI: 10.1016/0006-291X(72)90625-0  0.473
1972 Guillemin R, Amoss M, Blackwell R, Rivier J, Ling N, Vale W. On the biological activities of the synthetic tetrapeptide pyroglutamyl-tyrosyl-arginyl-tryptophanyl-amide. Biochemical and Biophysical Research Communications. 48: 1093-9. PMID 4560003 DOI: 10.1016/0006-291X(72)90821-2  0.473
1972 Monahan MW, Rivier J, Vale W, Guillemin R, Burgus R. (Gly 2 )LRF and des-His 2 -LRF. The synthesis, purification, and characterization of two LRF analogues antagonistic to LRF. Biochemical and Biophysical Research Communications. 47: 551-6. PMID 4556826 DOI: 10.1016/0006-291X(72)90914-X  0.473
1972 Vale W, Grant G, Rivier J, Monahan M, Amoss M, Blackwell R, Burgus R, Guillemin R. Synthetic polypeptide antagonists of the hypothalamic luteinizing hormone releasing factor. Science (New York, N.Y.). 176: 933-4. PMID 4555980 DOI: 10.1126/science.176.4037.933  0.473
1972 Burgus R, Butcher M, Amoss M, Ling N, Monahan M, Rivier J, Fellows R, Blackwell R, Vale W, Guillemin R. Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation). Proceedings of the National Academy of Sciences of the United States of America. 69: 278-82. PMID 4550508 DOI: 10.1073/PNAS.69.1.278  0.473
1972 Vale W, Brazeau P, Grant G, Nussey A, Burgus R, Rivier J, Ling N, Guillemin R. [Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone]. Comptes Rendus Hebdomadaires Des SéAnces De L'AcadéMie Des Sciences. SéRie D: Sciences Naturelles. 275: 2913-6. PMID 4347575  0.401
1971 Vale WW, Burgus R, Dunn TF, Guillemin R. In vitro plasma inactivation of thyrotropin releasing factor (TRF) and related peptides. Its inhibition by various means and by the synthetic dipeptide PCA-His-OME. Hormones. 2: 193-203. PMID 5006796 DOI: 10.1159/000178234  0.401
1971 Guillemin R, Burgus R, Vale W. The hypothalamic hypophysiotropic thyrotropin-releasing factor. Vitamins and Hormones. 29: 1-39. PMID 5002592 DOI: 10.1016/S0083-6729(08)60046-1  0.473
1971 Porter JC, Vale W, Burgus R, Mical RS, Guillemin R. Release of TSH by TRF infused directly into a pituitary stalk portal vessel. Endocrinology. 89: 1054-6. PMID 4999143 DOI: 10.1210/endo-89-4-1054  0.473
1971 Desiderio DM, Burgus R, Dunn TF, Vale W, Guillemin R, Ward DN. The elucidation of the primary structure of the hypothalamic thyroid stimulating hormone releasing factor of ovine origin by means of mass spectrometry Organic Mass Spectrometry. 5: 221-228. DOI: 10.1002/oms.1210050212  0.473
1970 Fleischer N, Burgus R, Vale W, Dunn T, Guillemin R. Preliminary observations on the effect of synthetic thyrotropin releasing factor on plasma thyrotropin levels in man. The Journal of Clinical Endocrinology and Metabolism. 31: 109-12. PMID 4987499 DOI: 10.1210/jcem-31-1-109  0.473
1970 Vale W, Burgus R, Dunn TF, Guillemin R. Release of TSH by oral administration of synthetic peptide derivatives with TRF activity. The Journal of Clinical Endocrinology and Metabolism. 30: 148-50. PMID 4984011 DOI: 10.1210/jcem-30-1-148  0.401
1970 Burgus R, Dunn TF, Desiderio DM, Ward DN, Vale W, Guillemin R, Felix AM, Gillessen D, Studer RO. Biological activity of synthetic polypeptide derivatives related to the structure of hypothalamic TRF. Endocrinology. 86: 573-82. PMID 4983136 DOI: 10.1210/endo-86-3-573  0.473
1968 Vale W, Burgus R, Guillemin R. On the Mechanism of Action of TRF: Effects of Cycloheximide and Actinomycin on the Release of TSH Stimulated in Vitro by TRF and its Inhibition by Thyroxine Neuroendocrinology. 3: 34-46. DOI: 10.1159/000121692  0.473
1967 Vale W, Burgus R, Guillemin R. Competition between thyroxine and TRF at the pituitary level in the release of TSH. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 125: 210-3. PMID 6028912 DOI: 10.3181/00379727-125-32051  0.401
1967 Davis TQ, Vale W, Guillemin R. Effects of Purified Thyrotropin Releasing Factor (TRF) on Thyrotropin (TSH) Release and Pituitary Acid Phosphatase Activity Neuroendocrinology. 2: 330-341. DOI: 10.1159/000121563  0.473
1967 Kastin AJ, Schally AV, Viosca S, Barrett L, Redding TW, D’Angelo SA, Hughes JS, Arai Y, Hiroi M, Mitra J, Gorski RA, Corbin A, Daniels EL, Davis TQ, Vale W, et al. Contents, Vol. 2, 1967 Neuroendocrinology. 2. DOI: 10.1159/000121555  0.42
Show low-probability matches.